Development of Clinically Translatable Technologies for Optical Image-Guided Breast Tumor Removal Surgery by Fu, Henry Li-wei
 i
v 
 
Development of Clinically Translatable Technologies for Optical Image-Guided Breast 
Tumor Removal Surgery 
by 
Henry Li-Wei Fu 
Department of Biomedical Engineering 
Duke University 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Nimmi Ramanujam, Supervisor 
 
___________________________ 
J. Quincy Brown 
 
___________________________ 
Adam P. Wax 
 
___________________________ 
David G. Kirsch 
 
___________________________ 
Joseph A. Izatt 
 
___________________________ 
Rebecca M. Willett 
 
Dissertation submitted in partial fulfillment of 
the requirements for the degree of Doctor 
of Philosophy in the Department of 
Biomedical Engineering in the Graduate School 
of Duke University 
 
2014 
 
  
ABSTRACT 
Development of Clinically Translatable Technologies for Optical Image-Guided Breast 
Tumor Removal Surgery 
by 
Henry Li-Wei Fu 
Department of Biomedical Engineering 
Duke University 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Nimmi Ramanujam, Supervisor 
 
___________________________ 
J. Quincy Brown 
 
___________________________ 
Adam P. Wax 
 
___________________________ 
David G. Kirsch 
 
___________________________ 
Joseph A. Izatt 
 
___________________________ 
Rebecca M. Willett 
 
An abstract of a dissertation submitted in partial fulfillment of 
the requirements for the degree of Doctor 
of Philosophy in the Department of 
Biomedical Engineering in the Graduate School 
of Duke University 
 
2014 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Henry Li-Wei Fu 
2014 
 
  
iv 
Abstract 
The rate of occurrence and number of deaths associated with cancer continues to 
climb each year despite the continual efforts to battle the disease.  When given a cancer 
diagnosis, it is particularly demoralizing and devastating news to a patient.  Generally, 
cancer is defined as the uncontrolled rapid growth of abnormal cells with metastatic 
potential.  In the cancer types originating from solid tissue or organ sites, a tumor will 
grow as a result of this rapid proliferation of cells.  Surgical resection is a commonly 
used as part of the treatment regimen prescribed for these types of cancer. 
Specifically in breast cancer, which impacts over 200,000 women a year, surgical 
intervention is used in almost 92% of treated cases.  A specific surgical procedure is 
known as breast conserving surgery (BCS), where the physician removes only the 
tumor, while retaining as much normal tissue as possible.  BCS is used in 59% of cases 
and is generally more preferable than the more radically mastectomy procedure where 
the entire breast is removed. 
To minimize the chance of local recurrence, it is vital that the tumor is completely 
removed and residual cancer cells are not still present in the patient.  This diagnosis is 
made by inspecting the edge of the resected tumor mass, typically known as the surgical 
margin.  If tumor cells are still present at the margin, then a positive diagnosis is given 
and tumor cells likely remain inside the patient.  Unfortunately, since margins are 
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typically diagnosed using post-operative pathology a patient with a positive margin 
must undergo a second re-excision operation to remove additional tissue. 
For breast cancer patients undergoing BCS, a staggering 20-70% of patients must 
undergo additional operations due to incomplete tumor removal during the first 
procedure.   
Currently, there are two intra-operative techniques that are used, frozen section 
analysis and touch prep cytology.  Although both have been proven to be effective in 
reducing re-excision rates, both techniques require 
There remains a clinical unmet need for an intra-operative technology capable of 
quickly diagnosis tumor margins during the initial surgical operation 
Optical technologies provide an attractive method of quickly and non-
destructively assessing tissue.  These techniques rely the interactions of light with tissue, 
which include absorption, scattering, and fluorescence.  Utilizing proper measurement 
systems, these interactions can be measured and exploited to yield specific sources of 
contrast in tissue.  In this dissertation, I have focused on developing two specific optical 
techniques for the purpose of surgical margin assessment.   
The first is diffuse reflectance spectroscopy (DRS) which is a specific method to 
extract quantitative biological composition of tissues has been used to discern tissue 
types in both pre-clinical and clinical cancer studies. Typically, diffuse reflectance 
spectroscopy systems are designed for single-point measurements. Clinically, an 
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imaging system would provide valuable spatial information on tissue composition. 
While it is feasible to build a multiplexed fiber-optic probe based spectral imaging 
system, these systems suffer from drawbacks with respect to cost and size. To address 
these I developed a compact and low cost system using a broadband light source with 
an 8-slot filter wheel for illumination and silicon photodiodes for detection. The spectral 
imaging system was tested on a set of tissue mimicking liquid phantoms which yielded 
an optical property extraction accuracy of 6.40 ± 7.78% for the absorption coefficient (µa) 
and 11.37 ± 19.62% for the wavelength-averaged reduced scattering coefficient (µs’). 
While DRS provided one potential approach to margin diagnosis, the technique 
was inherently limited in terms of lateral resolution.  The second optical technique I 
chose to focus on was fluorescence microscopy, which had the ability to achieve lateral 
resolution on the order of microns.  Cancer is associated with specific cellular 
morphological changes, such as increased nuclear size and crowding from rapidly 
proliferating cells.  In situ tissue imaging using fluorescent stains may be useful for 
intraoperative detection of residual cancer in surgical tumor margins.  I developed a 
widefield fluorescence structured illumination microscope (SIM) system with a single-
shot FOV of 2.1×1.6 mm (3.4 mm2) and sub-cellular resolution (4.4 µm).  The objectives 
of this work were to measure the relationship between illumination pattern frequency 
and optical sectioning strength and signal-to-noise ratio in turbid (i.e. thick) samples for 
selection of the optimum frequency, and to determine feasibility for detecting residual 
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cancer on tumor resection margins, using a genetically engineered primary mouse 
model of sarcoma.  The SIM system was tested in tissue mimicking solid phantoms with 
various scattering levels to determine impact of both turbidity and illumination 
frequency on two SIM metrics, optical section thickness and modulation depth.  To 
demonstrate preclinical feasibility, ex vivo 50 µm frozen sections and fresh intact thick 
tissue samples excised from a primary mouse model of sarcoma were stained with 
acridine orange, which stains cell nuclei, skeletal muscle, and collagenous stroma.  The 
cell nuclei were segmented using a high-pass filter algorithm, which allowed 
quantification of nuclear density.  The results showed that the optimal illumination 
frequency was 31.7 µm−1 used in conjunction with a 4x 0.1 NA objective.  This yielded an 
optical section thickness of 128 µm and an 8.9x contrast enhancement over uniform 
illumination.  I successfully demonstrated the ability to resolve cell nuclei in situ 
achieved via SIM, which allowed segmentation of nuclei from heterogeneous tissues in 
the presence of considerable background fluorescence.  Specifically, I demonstrated that 
optical sectioning of fresh intact thick tissues performed equivalently in regards to 
nuclear density quantification, to physical frozen sectioning and standard microscopy. 
However the development of the SIM system was only the first step in showing 
potential application to surgical margin assessment.  The nest study presented in this 
dissertation was to demonstrate clinical viability on a sample size of 23 animals.  The 
biological samples used in this study were a genetically engineered mouse model of 
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sarcoma, where a spontaneous solid tumor was grown in the hind leg.  After the tumor 
was surgically removed from the animal and the relevant margin was stained with 
acridine orange (AO), a simple and widely available contrast agent that brightly stains 
cell nuclei and fibrous tissues.  The margin was imaged with the SIM system with the 
primary goal of visualizing specific morphological changes in cell nuclei.  To 
automatically segment nuclei, an algorithm known as maximally stable extremal regions 
(MSER) was optimized and applied to the images.   
As an intermediate step prior to diagnosing whole margins, a tissue-type 
classification model was developed to differentiate localized regions (75x75 µm) of 
tumor from skeletal muscle and adipose tissue based on the MSER nuclei segmentation 
output.  A logistic regression model was used which yielded a final output in terms of 
probability (0-100%) the tumor within the localized region.  The model performance was 
tested using an ROC curve analysis that revealed a 77% sensitivity and 81% specificity.  
For margin classification, the whole margin image was divided into localized regions 
and this tissue-type classification model was applied.  In a subset of 6 margins (3 
negative, 3 positive), it was shown that at a tumor probability threshold of 50% only 8% 
of all regions from a negative margins exceeded this threshold, while over 25% of all 
regions exceeded the threshold in the positive margins. 
  
ix 
Dedication 
To my mother and father, Grace and Johnny Fu, whom having given me love 
and support my entire life.  And to Jerry Fu, whom has been a great and supportive 
older brother and friend. 
 
  
x 
Contents 
Abstract ......................................................................................................................................... iv 
List of Tables .............................................................................................................................. xiii 
List of Figures .............................................................................................................................. xv 
Symbols and Abbreviations ...................................................................................................... xxi 
1. Background and Significance .................................................................................................. 1 
1.1 Breast Conserving Surgery (BCS) ................................................................................... 1 
1.2 Existing Clinical Solutions............................................................................................... 3 
1.3 Emerging Optical Technologies for Margin Assessment ........................................... 4 
1.4 Optical Sources of Contrast in Breast Tissue ................................................................ 5 
1.5 Diffuse Reflectance Spectroscopy for Detecting Biochemical Signatures ................ 7 
1.5.1 Diffuse Reflectance Spectroscopy Principles ........................................................... 8 
1.5.2 Challenges Associated with Diffuse Reflectance Spectroscopy ............................ 9 
1.6 Fluorescence Microscopy for Visualizing Tumor Micro-Morphology ................... 10 
1.6.1 Challenges Associated with Fluorescence Microscopy ....................................... 12 
1.7 Objectives ......................................................................................................................... 15 
2. Improvements to the DRS imaging system ......................................................................... 17 
2.1 Methods ........................................................................................................................... 17 
2.1.1 System Design ............................................................................................................ 17 
2.1.2 Theoretical System Characterization: ..................................................................... 20 
2.1.3 Experimental System Characterization .................................................................. 24 
  
xi 
2.1.4 Monte Carlo Model of Diffuse Reflectance ............................................................ 27 
2.2 Results .............................................................................................................................. 28 
2.2.1 Theoretical Characterization Results ...................................................................... 30 
2.2.2 Experimental Characterization Results .................................................................. 31 
2.3 Conclusions ..................................................................................................................... 38 
3. Developing a SIM System for Margin Imaging .................................................................. 43 
3.1 Methods ........................................................................................................................... 46 
3.1.1 Structured Illumination Theory .............................................................................. 46 
3.1.2 System Design ............................................................................................................ 47 
3.1.3 System Imaging Parameters Characterization ...................................................... 50 
3.1.4 Tissue Phantom Preparation .................................................................................... 51 
3.1.5 Structured Illumination Characterization .............................................................. 52 
3.1.6 Imaging of Tumor Margins in a Primary Mouse Model of Soft Tissue Sarcoma
 ............................................................................................................................................... 57 
3.1.7 Quantitative Image Processing ................................................................................ 58 
3.2 Results .............................................................................................................................. 60 
3.2.1 Characterization of Imaging Parameters ............................................................... 60 
3.2.2 Characterization of Structured Illumination in Phantoms .......................................... 61 
3.2.3 Demonstration of System in a Mouse Model of Sarcoma .................................... 66 
3.2.4 Analysis of Images Using a HPF algorithm for Quantification of Nuclear 
Density ................................................................................................................................. 70 
3.3 Discussion ........................................................................................................................ 74 
4. Preclinical Validation of the SIM system ............................................................................. 80 
  
xii 
4.1 Methods ........................................................................................................................... 80 
4.1.1 Margin Imaging Protocol ......................................................................................... 80 
4.1.2 Image Processing Algorithm (MSER) ..................................................................... 83 
4.1.3 MSER Optimization Procedure ............................................................................... 84 
4.1.4 Tissue Type Classification Model ........................................................................... 86 
4.1.5 Logistic Regression .................................................................................................... 88 
4.2 Results .............................................................................................................................. 89 
4.2.1 Margin Imaging Results ........................................................................................... 89 
4.2.2 MSER Optimization Results .................................................................................... 90 
4.2.3 Tissue Type Classification Model Results .............................................................. 95 
4.2.4 Application to Full Margin Images ......................................................................... 98 
4.3 Discussion ...................................................................................................................... 102 
5. Conclusions ............................................................................................................................ 107 
5.1 Future Work .................................................................................................................. 113 
5.1.1 Combination of DRS and SIM Imaging ................................................................ 113 
5.1.2 SIM System Technical Improvements .................................................................. 115 
5.1.3 Identification of Additional Tissue Types ........................................................... 117 
5.1.4 Multi-spectral Contrast in SIM .............................................................................. 118 
5.1.5 Validation of Image Processing Algorithms ........................................................ 120 
References .................................................................................................................................. 123 
Biography ................................................................................................................................... 133 
  
xiii 
List of Tables 
Table 1:  Overview of different optical techniques applied to measuring breast tissue.  
The specific sources of contrast from each tissue site are also listed ..................................... 7 
Table 2: The median (over all measured samples) optical properties of three different 
tissue types encountered in our clinical studies.  The number of samples measured of 
each tissue type are also shown.  These optical properties are reported specifically for 
the shortest (450 nm) and longest (600 nm) wavelengths acquired in the clinical data. .. 22 
Table 3:  Table detailing the optical properties of 14 liquid phantoms (average value over 
400-600 nm) used to test the optical property extraction accuracy of the 3x3 compact 
optical spectral imaging system. The highlighted phantom was used as the reference 
phantom for the inversions using the scalable Monte Carlo model. ................................... 26 
Table 4:  Side-by-side comparison of key physical system parameters between the 
clinical system and compact optical spectral imaging system.  A noteworthy comparison 
is the large reduction of footprint in the compact system. .................................................... 30 
Table 5:  Comparison of the simulated sensing depth and cross-talk between the clinical 
system and the compact optical spectral imaging system. The sensing depth was 
simulated at two wavelengths, 450 nm and 600 nm, while cross-talk was only simulated 
at 600 nm. ..................................................................................................................................... 31 
Table 6:  Comparison of performance metrics between the clinical and compact optical 
spectral imaging systems.  The SNR of the clinical system was measured in a previous 
study (at 405 nm using a phantom with optical properties of µa = 7.5 cm-1 and µs’ = 16 cm-
1) ..................................................................................................................................................... 38 
Table 7:  Target design specifications for the SIM imaging system. .................................... 46 
Table 8:  List of illumination frequencies achieved at the sample plane for two different 
objective lenses ............................................................................................................................ 61 
Table 9:  The MSER parameters that are related to intensity.  A short description of the 
function of each parameter and range of values used during the optimization procedure 
is given. ......................................................................................................................................... 85 
Table 10:  Enrollment table for the number of mice imaged in this study.  The respective 
number of negative and positive margins as diagnosed by a trained pathologist using 
  
xiv 
post-operative H&E sections is also shown.   In some cases, the ink used to demarcate 
the relevant margin was lost during the fixing and staining process.  Within each 
classification, it is further specified whether the pathologist was able to find the ink on 
corresponding H&E. ................................................................................................................... 90 
Table 11:  The estimated coefficients from the logistic regression model for classifying 
tissue types. .................................................................................................................................. 97 
Table 12:  Comparison of the two optical systems which were develop for surgical tumor 
margin assessment .................................................................................................................... 113 
 
 
  
xv 
List of Figures 
Figure 1: A graphic which depicts the difference between a positive and negative 
surgical margin.  A cross-section of each excised sample is shown, where A – cancer 
cells, B – normal cells, C – margin of lumpectomy.  Clearly in the positive margin, the 
cancer cells are present at the margin which indicates cancer cells remain inside the 
patient. ............................................................................................................................................ 3 
Figure 2:  Graphic which details the human breast anatomy.  Optical sources of contrast 
are also specifically indicated.  Absorption generally occurs in hemoglobin molecules 
(located in blood vessels) and β-carotene (stored in fat tissue).  Scattering occurs as a 
result of cells and collagen connective tissue. ........................................................................... 6 
Figure 3:  Basic principle of DRS demonstrating absorption and scattering inside tissue.  
An example of a measured spectrum is shown on the right .................................................. 9 
Figure 4: Overview of the two spectral imaging systems. A) A system schematic of the 
current clinical spectral imaging system.  This figure contains a block diagram of the 
system as well as a detailed diagram of the probe tip. B) A system schematic of the 
compact optical spectral imaging system which details the illumination and collection 
setup. C) Photograph of the tip of the 3x3 photodiode array.  The numbers represent the 
pixel numbers, which will be referred to throughout the manuscript. ............................... 19 
Figure 5:  System photographs to compare physical size A) Photograph of the modified 
3x3 compact optical spectral  imaging system compared to the B) Photograph of the 
clinical system.  The same laptop is pictured in both system photographs in order to 
compare system scale ................................................................................................................. 29 
Figure 6: A) Signal-to-noise ratio (SNR) for all pixels at three different wavelengths (400, 
500, 600 nm). The SNR was calculated by taking 15 repeated measurements on a liquid 
phantom and dividing the mean by the standard deviation.  The optical properties of the 
phantom used in the SNR measurements were µa = 7.00 cm-1 and µs’ = 14.84 cm-1. B) The 
table on the right indicates the optical power output (at 400 nm) from the illumination 
fiber of each pixel. ....................................................................................................................... 32 
Figure 7:  A) Normalized (to reflectance value at 600 nm) diffuse reflectance spectrum 
collected from phantom 14 using the clinical and compact optical spectral imaging 
systems, corrected with a reflectance standard and reference phantom.  The plots 
demonstrated reasonable agreement between the two systems. B) Measured and 
  
xvi 
modeled diffuse reflectance spectra from the compact optical spectral imaging system.  
These spectra are not normalized but are corrected with a reflectance standard. ............ 34 
Figure 8:  Photographs of pixels 5 and 7 demonstrating the physical defect in pixel 7.  
Note difference in the central illumination fiber in both pixels.  As noted in the 
representative spectra, all pixels match the clinical system aside from pixel #7. .............. 35 
Figure 9:  Plots of the optical property extraction accuracy averaged over pixels #1, 2, 3, 
4, 5, 6, and 9 of the compact optical spectral imaging system.  The data presented is the 
wavelength averaged µa and µs’ for all 14 liquid phantoms.  Average extraction errors 
for each individual pixel are displayed in following figure. ................................................ 36 
Figure 10:  Summary of the optical property (µa and µs’ averaged over all wavelengths) 
extraction errors for all pixels.  The errors shown here are the average errors over all 14 
target phantoms.  Phantom #4 (µa = 2.00 cm-1; µs’ = 19.22 cm-1) was used as the reference 
phantom for the inversions........................................................................................................ 37 
Figure 11:  An example of a DRS image acquired with a clinical system on human 
lumpectomy specimen.  Based on the β-carotene to µs’ ratio, sites 1 and 2 both appear 
could potentially be malignant sites.  However, as the pathology reveals, only site 1 
corresponds to malignancy, while site 2 corresponds to normal fibro-glandular tissue. . 43 
Figure 12: Detailed schematic of the SIM imaging system.  The 𝜆ex peak was 480 nm and 
the 𝜆em peak was 520 nm.  The spatial filter diameter was adjusted to allow only the 0 
and +1 diffraction orders to pass.  An image of group 7 of the USAF resolution target 
acquired by the system is also shown. ..................................................................................... 49 
Figure 13: Schematic demonstrating the method used to measure the optical sectioning 
strength of the imaging system.  Also shown is a detailed diagram of the structure of the 
solid phantom used for measurement.  Three separate phantoms were creating with 
increasing levels, µs’ = 0, 10, 20 cm-1. ........................................................................................ 53 
Figure 14:  Images of a single layer of 10 µm fluorescent spheres embedded in PDMS 
and TiO2.  The reduced scattering coefficient of the phantom is approximately 10 cm-1.  
Images were taking using a 4x NA = 0.1 objective and an illumination frequency of 31.7 
mm-1.  The improvement in contrast is clearly seen from the uniform to structured 
illumination image.  The signal-to-background was calculated by taking the intensity of 
5 manually selected spheres (indicated by red arrows) and dividing by the background 
ROI (indicated by the blue square).  All scale bars are 100 µm ............................................ 62 
  
xvii 
Figure 15:  Optical section thickness measurements from solid phantoms. (A) Plot of the 
mean image intensity as a function of distance from focal plane used to determine 
optical section thickness. The circles represent data that was acquired on the µs’ = 0 cm-1 
phantom using a 4x NA = 0.1 objective with an illumination frequency of 19.6 mm-1.  The 
solid line represents the Stokseth approximation (Eq. 4) calculated using the same 
variables. (B) Plot relating optical section thickness to illumination grid frequency for a 
range of reduced scattering coefficients. The datapoints represent the measured values 
on phantoms, and the solid line represent the theoretical value calculated using the 
Stokseth approximation.  The dotted arrows show how the optical section thickness was 
measured on the left and how it was placed on the corresponding plot on the right. ..... 64 
Figure 16:  Modulation depth as a function of grid frequency for non-scattering 
phantoms and scattering phantoms (two µs’ levels).  The points labeled A and B are 
referenced in the Discussion section. ....................................................................................... 65 
Figure 17: SNR ratio (uniform SNR to sectioned SNR) versus modulation depth for non-
scattering and scattering phantoms.  The points labeled A and B are referenced in the 
Discussion section. ...................................................................................................................... 66 
Figure 18:  Images of a 50 µm tissue slice demonstrating the correlation between images 
acquired by the SIM system and H&E histological micrograph.  SIM images were taking 
using the 4x objective and a frequency of 31.7 mm-1.  H&E images were taken using a 
2.5x objective and the images were cropped to match one another.  Site imaged on tissue 
contains both cross sectional skeletal muscle (M) and sarcoma tumor (T).  The arrows on 
each image point out a site where tumor tissue was invading into the normal skeletal 
muscle.  Scale bars are 100 µm. ................................................................................................. 67 
Figure 19:  Uniform and structured illumination images acquired from mouse tissue. (A) 
Images of skeletal muscle from mouse.  Both longitudinal and cross-sectional muscle can 
be seen in the region of interest (B) Image of tumor tissue from mouse sarcoma.  Cell 
nuclei are the only source of contrast apparent in these images.  Contrast enhancement is 
clearly seen in the sectioned images (acquired at f = 31.7 mm-1).  Scale bars are 100 µm. 70 
Figure 20:  Fluorescent images of mouse sarcoma tissue processed using a high-pass 
filter (HPF) algorithm to isolate cell nuclei.  The in situ sectioned image (acquired using f 
= 31.7 mm-1) .................................................................................................................................. 71 
Figure 21:  Results demonstrating the impact of illumination frequency on quantification 
of cell nuclei density. (A) Sectioned images of mouse sarcoma tissue at multiple 
illumination frequencies.  The corresponding HPF processed images are shown which 
  
xviii 
demonstrate the isolation of cell nuclei.  (B) Mean density of cell nuclei extracted from 
images mouse sarcoma tissue.  The nuclear density extracted from the 50 µm thick 
frozen section images (N=9) was compared to density extracted from in situ tissue 
imaging (N=5), both uniform and sectioned (f = 47.7, 31.7, 24.1 mm-1) images. ................. 73 
Figure 22:  Flowchart demonstrating the imaging protocol immediately after the tumor 
margin was removed from the transgenic sarcoma model.  After the procedure above 
was completed, the tissue sections were inked to identify the area imaged, stained with 
H&E and submitted to pathology. ........................................................................................... 82 
Figure 23:  A) Overview of the maximally stable extremal regions (MSER) algorithm.  
This algorithm, which is used in the automatic reconstruction of 3D scenes was selected 
as it was a more robust approach than a simple global image threshold.  MSER tests all 
intensities thresholds within the image to ensure local maxima within various 
background intensities are not lost.  B) A detailed description and visual representation 
of the five variable parameters used in MSER, MinArea, MaxArea, Delta, MaxVariation, 
and MinDiversity. ....................................................................................................................... 84 
Figure 24:  Methodology for calculating area fraction of a MSER segmented image.  Area 
fraction was the metric used to quantify the performance of the MSER algorithm. ......... 86 
Figure 25:  Flow chart which demonstrates the quantitative analysis carried out on the 
site specific ROIs.  The purpose of this analysis was to develop a predictive model to 
differentiate tumor tissue from muscle and adipose.  A total of 30 images were used as a 
training dataset to develop the model.  Each image was further divided into smaller bins 
to ensure very localized disease could be detected.  Finally, three quantities were 
calculated for each bin, area fraction, average diameter, and average shape, and used as 
input variables for a logistic regression model. ...................................................................... 87 
Figure 26:  Representative SIM images of three different tissue types commonly found in 
margin images, tumor, muscle, and adipose tissues.  For the smaller ROIs, both the 
sectioned and uniform images are shown to demonstrate the enhanced contrast that SIM 
provides.  Examples of H&E micrographs are also shown, but it should be noted the 
H&E is not taken from the exact site of the corresponding SIM images. ............................ 91 
Figure 27:  Plots that demonstrate the effect of three different MSER parameters on 
segmented area fraction for tumor, muscle, and adipose images (Shown in previous 
figure).  The parameter Delta shows the most impact on area fraction, while 
MaxVariation and MinDiversity have a minimal effect. ....................................................... 92 
  
xix 
Figure 28:  Series of images which demonstrate the impact of changing Delta on MSER 
nuclei segmentation.  The calculated area fraction for each image is displayed on the 
bottom right.  As shown in the previous plot, the segmented area fraction varies greatly 
as Delta changes. Ultimately, a Delta value of 10 was chosen as the segmented nuclei 
appeared to be the most physiologically accurate. ................................................................ 93 
Figure 29:  Application of the finalized set of MSER parameters to both the uniform and 
sectioned representative image set.  It is evident that the sectioned images provide a 
clear benefit with contrast enhancement which assists the MSER algorithm in accurately 
identifying nuclei.  The finalized set of MSER parameters used for these segmentation 
results were MinArea=3, MaxArea=15, MinDiversity=0.5, MaxVariation=2.5, and 
Delta=10. ....................................................................................................................................... 95 
Figure 30:  Distribution functions of the three variables, area fraction, diameter, and 
shape.  These include all 50x50 pixel bins from the training dataset, N=420 tumor bins 
and N=840 normal bins (420 muscle and 420 adipose).  A Wilcoxon rank-sum test was 
used to compare the distributions and calculate the corresponding p-value.  Based on 
the results, the tumor and normal distributions were statistically different in all three 
variables, so they were included as input to the logistic regression model. ...................... 96 
Figure 31:  The receiver operating characteristic (ROC) curve on the left was generated 
when logistic regression model was applied to the original training dataset of 30 site 
specific ROIs (10 tumor sites and 20 normal sites).  The specific combinations of 
variables used as input to the logistic regression model are shown in the legend.  The 
ROC curve on the right was the result of applying the same logistic regression model on 
separate validation dataset containing 25 new site specific ROIs (10 tumor sites and 15 
normal sites). ................................................................................................................................ 97 
Figure 32:  Example of a positive and negative margin imaged with the SIM system.  
These images were viewed by a pathologist who labeled likely regions of tumor (T) and 
muscle (M).................................................................................................................................... 99 
Figure 33:  These are the same positive and negative margin examples from the previous 
figure.  The images have been analyzed with MSER and the segmented nuclei are 
highlighted in green. ................................................................................................................ 100 
Figure 34:  Each margin was divided into smaller 50x50 pixel bins and each bin was 
analyzed using the site level predictive model.  Based on the output of the model, a 
tumor probability (%) was assigned to each bin.  As expected, the CDFs from the 
sectioned images (left) show a larger portion of the positive margin bins were assigned a 
  
xx 
higher tumor probability resulting in clear separation between the positive and negative 
margin CDF.  However, the CDFs from uniform illumination images (right) did not 
exhibit as much separation, indicating the importance of the contrast enhancement using 
SIM. ............................................................................................................................................. 101 
Figure 35:  A system schematic for a combination DRS and SIM imaging system.  The 
primary advantage would be to utilize the fast scanning and coverage ability of DRS, 
while also maintain the ability to visualize high-risk regions with the high spatial 
resolution of SIM ....................................................................................................................... 114 
Figure 36:  Images of a nerve bundle, bone, and bone marrow acquired with the SIM 
system.  These tissue types were not as common as tumor, muscle, or adipose, however 
due to their high cellular contact these were a source of false negatives in the margin 
images.  Scale bars are 200 µm. ............................................................................................... 118 
Figure 37:  Multi-spectral properties of AO. (a) An tissue section image of tumor + 
muscle imaged with all emission wavelengths. (b) An overlay of 530 (green) and 630 nm 
(red) emission. (c) Corresponding H&E stained section. .................................................... 120 
 
 
 
 
 
 
 
 
 
 
  
xxi 
Symbols and Abbreviations 
βc – β-carotene 
µa – absorption coefficient 
µs – scattering coefficient 
µs’ – reduced scattering coefficient, µs*(1-g) 
µm – micrometer or micron 
< > – average value 
σ – standard deviation 
[ ] – concentration 
AO – acridine orange 
AUC – area under the curve 
BCS – breast-conserving surgery 
CCD – charge-coupled device 
CDF – cumulative distribution function 
DRS – diffuse reflectance spectroscopy 
FOV – field of view 
H&E – hemotoxylin and eosin 
Hb – hemoglobin or total hemoglobin 
HbH – deoxy-hemoglobin 
HbO2 – oxy-hemoglobin 
  
xxii 
HPF – high-pass filter 
MSER – maximally stable extremal regions 
NA – numerical aperture 
n – sample size 
nm – nanometer 
RFP – red fluorescent protein 
ROC – receiver operating characteristic 
ROI – region of interest 
SIM – structured illumination microscopy 
SLM – spatial light modulator 
SNR – signal-to-noise ratio 
  
xxiii 
Acknowledgements 
First and foremost I give thanks and praise to the Lord our God, without whom 
absolutely none of this would be possible.  He is indeed good and has blessed me with 
the wonderful people, opportunity, and resources, during this journey. 
I want to sincerely thank Nimmi Ramanujam for graciously giving me the 
opportunity to succeed at Duke.  Her desire to further scientific research and genuine 
concern for patient healthcare has truly inspired my work and academic growth.  I also 
want to thank all other members of my committee, Dr. Adam Wax, Dr. David Kirsch, 
Dr. Joe Izatt, and Dr. Rebecca Willett.  All of your guidance and input through this 
process has been greatly appreciated.  
 I also want to thank all members of the TOpS lab whom I’ve had the pleasure of 
working with through my time at Duke.  Specifically Dr. Quincy Brown, Dr. Bing Yu, 
Dr. Justin Lo, and Jenna Mueller who I have worked closely with on the projects in this 
dissertation.  Additionally, Dr. Karthik Vishwanath, Dr. Naras Rajaram, Marlee Krieger, 
Dr. Janelle Bender, Dr. Stacy Millon, Dr. Vivide Chang, Dr. Torre Bydlon, Dr. Stephanie 
Kennedy, Amy Frees, Fangyao Hu, Brandon Nichols, Chris Lam, Nada Hussein, and 
Brian Crouch.  All are brilliant individuals and truly have the potential to achieve great 
things.  I also want to thank the members of the Kirsch Lab, Dr. Jeffrey Mito and Melodi 
Whitely who helped extensively with the mouse sarcoma model.  Finally, I also want to 
  
xxiv 
thank the members of the Willett lab that have helped with the image processing 
algorithms, Dr. Zach Harmany and Albert Oh. 
  1 
1. Background and Significance  
Cancer is a complex and devastating disease that is continually among the top 
causes of death worldwide.  Its heterogeneous nature and impact on virtually all cell 
types and organ sites pose challenges to current treatments.  In 2014, it is estimated that 
1,665,540 new cases of cancer will be diagnosed, equivalent to about 4,500 new 
diagnoses per day [1].  For men and women, the most common occurring cancer type is 
prostate and breast cancer, respectively, with over 230,000 estimated new cases of each.  
In cancers originating from these two tissue types, the disease manifests itself as a 
physical tumor due to the unregulated and increased replication of cancer cells.  
Obviously, this prognosis is not limited to only these two organ sites, but virtually all 
types of cancer except for leukemias (cancer of the blood).  To treat these solid tumors, 
surgical intervention is commonly used to de-bulk the mass.  In prostate cancer, surgery 
is prescribed as part of the treatment 48% of cases and in breast cancer, surgery is used 
92% of cases [2].  Unfortunately, there are specific shortcomings of surgical treatments 
that will be outlined in this section, with a focus on breast cancer due to its 
overwhelming prevalence. 
1.1 Breast Conserving Surgery (BCS) 
In 2009, almost 200,000 women with early stage breast cancer and/or carcinoma 
in situ (CIS) received breast conserving surgery (BCS) [3]. BCS involves removal of 
malignant tissue with a surrounding margin of normal breast tissue.  BCS is the 
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preferred method of surgical treatment as opposed to the more radical mastectomy 
procedure where the entire breast is removed [4].  Post-operative histopathologic 
assessment of the resected specimen is the current gold standard by which microscopic 
residual tumor in the margin is detected. Post-operative positive pathologic margin 
status is an important predictor of local recurrence of an invasive or in-situ cancer after 
BCS [5, 6].  A re-excision surgery is performed if residual cancer is found within 2 mm of 
the surface of the excised lumpectomy specimen, in order to reduce the risk of 
recurrence [7].  The cartoon shown in Figure 1 depicts the difference between a positive 
and negative margin.   
Recently, meta-analyses by the Early Breast Cancer Trialists group showed that 
one death is averted for every four women in which a local recurrence is avoided. A 
literature review indicates that as many as 20-70% of BCS patients undergo re-excision 
surgery because the cancer was incompletely removed during the first BCS [8-13]. This 
represents an enormous physical burden to the patient (increasing her chances for 
surgical complications and/or eventual cancer-related mortality) and financial burden to 
the health care system (effectively doubling the cost of treatment for this group of 
patients). By 2015, it is expected that the number of patients undergoing BCS will rise 
from approximately 200,000 to more than 270,000 per year in the U.S., at an annual 
growth rate of 5.5% [3]. With no industry standard to prevent re-excision, it is expected 
that there will be a concomitant rise in the number of re-excision surgeries. 
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Figure 1: A graphic which depicts the difference between a positive and 
negative surgical margin.  A cross-section of each excised sample is shown, where A – 
cancer cells, B – normal cells, C – margin of lumpectomy.  Clearly in the positive 
margin, the cancer cells are present at the margin which indicates cancer cells remain 
inside the patient. 
1.2 Existing Clinical Solutions 
Currently there are two clinically used intraoperative techniques that are 
employed to assist surgeons in the operating room.  The first technique is frozen section, 
where the specimen is immediately flash-frozen and sectioned [14-17].  These tissue 
sections are stained with hematoxylin and eosin (H&E) then sent to a pathologist for an 
immediate diagnosis that is relayed back to the surgeon.  The second technique is 
imprint or touch-prep cytology [18, 19].  Once the specimen has been removed, the 
margin is touched to a glass slide wthat is inspected by a trained cytologist.  Both of 
these techniques have demonstrated success in reducing re-excision rates by up to 34% 
[20].  
Intra-operative frozen section analysis and touch-prep cytology are used to 
assess surgical margins at the time of first surgery at a few select high-volume centers 
with dedicated resources and personnel. However, these techniques have not been 
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widely adopted because of (1) the need for pathologists in the operating room, (2) 
prolonged time during surgery for specimen processing (20-40 minutes), (3) technical 
challenges associated with processing fatty breast tissues, and (4) suboptimal sensitivity 
of gross pathologic evaluation to guide where to cut the sample for microscopic margin 
assessment (since the entire specimen cannot be practically sampled). The most common 
practice is for the breast surgeon to perform intra-operative gross examination and 
specimen mammography to determine if an adequate excision has been achieved, with 
pathologic examination of microscopic disease carried out only after the surgery has 
been completed.  This literature review and analysis of current clinical procedures 
indicates that there is an unmet need for an intra-operative tool capable of 
distinguishing positive and negative breast tumor margins. 
1.3 Emerging Optical Technologies for Margin Assessment 
Optical techniques provide a unique, non-destructive approach to characterizing 
the biological composition of tissue.  These techniques rely on the unique interactions of 
optical radiation with tissue.  These specific interactions include optical absorption, 
where the optical radiation is simply absorbed by the tissue, and scattering, occurs when 
the optical radiation is re-directed by the tissue.  In some techniques optical fluorescence 
is used where certain molecules absorb optical radiation but quickly re-emit light of a 
lower energy.  These molecules, known as fluorophores, can either be endogenous, 
occurring naturally in tissue, or exogenous, an externally added contrast agent to 
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enhance the fluorescent properties of the tissue.  Optical technologies are particularly 
since optical radiation (400-1300 nm) is non-ionizing and generally safe for biological 
use. 
A number of academic [15, 18, 21-30] and commercial [31-36] groups have 
worked on or are developing tools for intra-operative assessment of breast tumors. A 
number of groups have published on the use of optical spectroscopy, in particular 
diffuse reflectance, fluorescence and/or Raman spectroscopy for the diagnosis of breast 
cancer - a pair of recent review articles covers these studies in more detail [37, 38]. The 
majority of groups have studied breast biopsies and collectively shown that the primary 
sources of intrinsic contrast in breast cancer are alterations in cell density, fat and 
collagen content as well as tissue vascularity. 
1.4 Optical Sources of Contrast in Breast Tissue 
The major endogenous absorbers in the visible spectrum in breast tissue are 
oxygenated and deoxygenated hemoglobin (HbO2 and HbH) and β-carotene (βc), which 
are directly related to blood content, oxygenation, and adipocytes.  Each of these 
absorbers exhibits a unique wavelength-dependent spectral characteristics depending on 
its concentration.  In addition to absorption, some biological factors contribute to optical 
scattering, such as the size and density of cells and the structure of collagen, which 
provides structure and support for the tissue. 
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Figure 2:  Graphic which details the human breast anatomy.  Optical sources of 
contrast are also specifically indicated.  Absorption generally occurs in hemoglobin 
molecules (located in blood vessels) and β-carotene (stored in fat tissue).  Scattering 
occurs as a result of cells and collagen connective tissue. 
Figure 2 is a cartoon of the human breast with arrows pointing to the major 
sources of optical contrast due to absorption and scattering.  Cellular structures and 
collagen in the breast cause light to scatter. The optical absorbers in breast tissue are 
HbO2 and HbH, present in blood vessels and βc, typically stored in adipocytes (fat cells).  
Additionally, NADH and FAD are fluorescent molecules that re-emit light when 
illuminated with the proper excitation wavelength. 
The optical technologies capable of measuring the specific breast composition are 
listed in Table 1.  From previous studies, it was shown that the main sources of optical 
contrast for differentiating benign from malignant tissues are related to breast 
vasculature (Hb), fat (indirectly measured via βc content), collagen, and cells. 
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Table 1:  Overview of different optical techniques applied to measuring breast 
tissue.  The specific sources of contrast from each tissue site are also listed 
Optical  
Technique  
Tissue Interrogated  Source of Contrast  
Diffuse reflectance & 
elastic scattering 
spectroscopy 
[34, 36, 39-47] 
adipocytes  
cells & collagen  
blood  
βc  
scattering  
HbO2  
HbH  
Near-infrared  
spectral imaging  
[48-52] 
water  
cells & collagen  
adipocytes  
blood  
water  
scattering  
Lipids  
HbO2  
HbH  
Fluorescence  
spectroscopy  
[39, 41, 43, 45, 47, 53] 
collagen fibers  
cells  
collagen  
NADH, FAD,  
retinol, tryptophan  
Raman spectroscopy  
[21, 54-56] 
blood  
adipocytes  
variety of cells  
heme  
lipids  
carotenoids  
tryptophan  
cholesterol  
Optical coherence 
tomography  
[22, 57] 
cells  
sub-cellular organelles  
scattering  
 
1.5 Diffuse Reflectance Spectroscopy for Detecting Biochemical 
Signatures  
Diffuse reflectance spectroscopy (DRS) is one such technique which, when 
coupled with appropriate light transport models, is capable of extracting quantitative 
information about tissue absorption and scattering, both of which reflect underlying 
tissue composition [40, 45, 58-61].  Zhu et al. established the underlying sources of 
optical contrast between malignant and non-malignant breast tissues that can be 
exploited for intra-operative margin assessment and her results are very consistent with 
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other similar studies reported in the literature [45-47, 62].  She found a statistically 
significant decrease in beta-carotene and total hemoglobin concentration and statistically 
significant increase in wavelength-averaged reduced scattering coefficient in malignant 
over non-malignant tissues.  Our group has developed a quantitative diffuse reflectance 
spectral imaging device to exploit these intrinsic sources of optical contrast for the 
imaging of breast tumor margins [37, 63, 64]. In an initial 48 patients, the technology had 
a sensitivity and specificity of 80% and 67%, respectively, for detection of residual cancer 
on the margins of excised specimens [64]. In a later cohort of 92 margins from 72 
patients, the technology had a sensitivity and specificity of 89% and 70%, respectively 
[65]. 
1.5.1 Diffuse Reflectance Spectroscopy Principles 
Briefly, DRS is an optical technique which exploits the absorption and scattering 
properties of a given sample.  Figure 3 shows a graphical depiction of interrogating a 
tissue specimen with DRS.  Traditionally, light is traditionally delivered to the sample 
using an optical fiber.  Once the light has entered the tissue, it will either be absorbed or 
scattered.  Some portion of the light scattered toward the surface of the tissue, which is 
collected by an adjacent optical fiber.  This light remitted from the tissue is known as the 
diffuse reflectance.  The absorption and scattering properties of tissue are wavelength-
dependent, so the diffuse reflectance can be measured over a range of wavelengths to 
construct a full diffuse reflectance spectrum.  An example spectrum is shown on the 
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right side of Figure 3, where the unique absorption properties of β-carotene and 
hemoglobin (α, β, and Sorét band) are clearly seen.  The spectrum is typically analyzed 
using a predictive photon migration model that is capable of extracting and quantifying 
the absorption (µs) and scattering (µs) coefficient.  The absorption coefficient, µa, is 
equivalent to the inverse of the mean free path of a photon before undergoing an 
absorption event.  Similarly, µs is the inverse of the mean free path before undergoing a 
scattering event.  Reduced scattering coefficient is often reported, which is simply µs*(1-
g), where the anisotropy coefficient, g, is the average cosine of the scattering angle. 
 
Figure 3:  Basic principle of DRS demonstrating absorption and scattering 
inside tissue.  An example of a measured spectrum is shown on the right 
1.5.2 Challenges Associated with Diffuse Reflectance Spectroscopy 
As previously mentioned, our group recently developed and clinically tested an 
optical spectral imaging system based on DRS to quantitatively image ex vivo breast 
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tumor margins for the detection of residual disease [66].  To briefly summarize, the 
system consists of a Xenon arc lamp, spectrograph, and a 2D CCD camera.  
Traditionally, a single-channel fiber-optic probe is used for single-point spectroscopy. 
However, for the margin assessment application, our single-channel probe was replaced 
with an imaging probe comprised of 8 independent channels, each containing its own 
set of illumination and collection fibers.  Each measured diffuse reflectance spectrum 
was analyzed using an inverse Monte Carlo model previously developed by our group, 
to extract beta-carotene concentration, oxy-hemoglobin concentration, de-oxy 
hemoglobin concentration, and a wavelength-averaged reduced scattering coefficient.  
While our clinical studies have demonstrated feasibility of optical spectral imaging for 
the detection of positive tumor margins, the system’s large physical footprint (2 m x 1.5 
m x 1 m) and significant cost (~$55,000) potentially limit its widespread clinical utility. In 
addition, the number of channels in the clinical system is limited by the number of 
collection fibers that can be imaged by the CCD (while minimizing cross-talk between 
adjacent channels) and thus multiple placements (and increased time) are required to 
fully survey breast tumor margins, which can be as large as 10-20 cm2. 
 
1.6 Fluorescence Microscopy for Visualizing Tumor Micro-
Morphology 
The quantitative spectral imaging system provides one optical based strategy for 
visualizing tumor margins, but there is an inherent lack of spatial resolution due to the 
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nature of diffuse reflectance spectroscopy.  Specifically, spectroscopy is unable to 
visualize the cellular changes that occur in breast tumors on the microscopic level as 
optical spectroscopy relies on multiple scattered diffuse photons.  In addition, it can be 
difficult to distinguish scattering signatures from malignant tissues and fibro-glandular 
tissues, which can result in a reduction in diagnostic accuracy.  Increasing nuclear size 
and crowding of nuclei due to rapidly proliferating cells, are common characteristics in 
cancer.  These changes have long been exploited for diagnosis in ex vivo tissue using 
Hemotoxylin and Eosin (H & E) staining, where pathologists observe microstructural 
features including nuclear size and shape and nuclear density to determine the 
pathologic state of the tissue.   
There is evidence in the literature of the success of in high resolution optical 
imaging. For example, Gareau et al. have published a series of papers employing 
confocal reflectance and fluorescence microscopy in combination with acridine orange 
(AO) staining of nuclei for tumor margin assessment of skin cancer ex vivo [67-72]. This 
approach exploited subjective human observation of the images to detect basal cell 
carcinomas with 97% sensitivity and 89% specificity. A recent study by Nyirenda et al. 
[73], employed UV-excited DAPI to stain cell DNA ex vivo in rat mammary tumor 
xenografts and human breast tissue microarrays.  The authors demonstrated that they 
could detect rodent tumors with greater than 95% sensitivity and specificity using 
automated calculation of inter-nuclear distance. Richards-Kortum et al. have developed 
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a high resolution fluorescence microendoscope (HRME) and used it in conjunction with 
acriflavine to image dysplasia and early cancer in the oral cavity and esophagus [74, 75]. 
Esophageal images collected ex vivo were analyzed both subjectively by expert clinicians 
yielding a sensitivity and specificity of 87% and 61%, and quantitatively through the 
application of algorithms that focused on spatial frequency content and pixel pair 
correlation (internuclear distance) yielding a sensitivity and specificity of 87% and 85% 
[75].  Gmitro’s group has published a number of studies on confocal laser scanning 
microendoscopy of AO stained tissue [76-79].  In an ex vivo ovarian study, they showed 
that automated classification algorithms leveraging texture could diagnose ovarian 
cancer with better than 95% sensitivity and 90% specificity [76].  They have developed a 
mobile confocal endoscopy system, and shown images of microanatomical and nuclear 
detail from the ovary in vivo and ex vivo using AO as a contrast agent (under IND 
approval) [77]. 
1.6.1 Challenges Associated with Fluorescence Microscopy 
Our group has recently demonstrated the viability of visualizing tumor 
microanatomy using a high resolution micro-endoscope system (HRME) [74, 80].  A 
coherent imaging fiber bundle is a central component of the HRME system used in the 
preliminary studies, which requires physical contact with the specimen and provides 
small field of view (0.63 mm2).  These two constraints limit the application of the system 
in diagnosing the entire tumor surface.  It is the goal of this aim to design and construct 
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a new wide-field optical sectioning microscope that does not require a coherent imaging 
fiber bundle.  The system will also be designed to capture the entire field of view in a 
single exposure rather than a point by point scanning (i.e. confocal microscopy), due to 
the speed advantage of wide-field imaging. 
Based on the literature of existing and developing technologies, leveraging the 
changes in tissue microanatomy that occur in cancer development can yield very 
informative diagnostic information for accurate margin assessment.  These cellular 
changes, particularly related to the cell nuclei, can only be investigated using high 
resolution optical methods.  The current limitation with these optical imaging methods 
is that there is perceived trade-off between imaging at high resolution and area of 
coverage.  Indeed, a typical breast tumor margin is on the order of 4x4 cm, whereas the 
field of view on a microscope with a 10x objective may be around 0.1 x 0.1 cm.   
Another challenge is that in conventional non-contact fluorescence microscopy, the 
entire field of view is uniformly illuminated with the excitation light.  This creates a 
problem as fluorophores outside the plane of focus are also excited and emit photons, 
generating a significant amount of unwanted background fluorescence. This in turn 
significantly degrades contrast of features of interest in the focal plane.  This is a 
common issue in widefield fluorescence microscopy and several specialized techniques 
exist to reject background fluorescence, such as fluorescence confocal microscopy.  In 
fact, Gareau et al. recently reported a custom fluorescence confocal microscopy system 
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designed to image and diagnose margins during Mohs procedures for removal of skin 
cancer [81].  While extremely effective in rejecting background fluorescence and capable 
of exquisite image quality, confocal microscopy typically relies on sequential pixel 
scanning, in which a laser beam is focused to a diffraction-limited spot and scanned over 
the sample in time.  Confocal scanning approaches which aim to parallelize the 
acquisition process, such as spinning disk confocal and line-scan confocal, serve to 
increase the effective pixel sampling rate, but not without limitations (spinning disk 
confocal is limited in the adjustment of axial resolution, and line scan confocal with 
linear CCDs results in possibly asymmetric lateral resolution along the line dimension).   
An alternative approach to reject background fluorescence with fully parallel pixel 
detection is structured illumination microscopy (SIM), in which the entire field of view 
is illuminated with a defined spatial pattern and scanning of a focal spot is not required 
[82].  Other than the use of patterned illumination, the illumination and collection 
geometry is identical to that of conventional widefield fluorescence microscopy, so a 
standard CCD may be used for detection.  The advantages of structured illumination 
microscopy are that 1) optically-sectioned images are obtained with all pixels in parallel, 
thereby significantly increasing the pixel sampling rates, 2) CCD detectors with high 
quantum efficiency can be used making SIM light-efficient, 3) the axial resolution can be 
tuned by varying pattern frequency, and the lateral resolution is symmetric over the 
field of view, and 4) it is a relatively low complexity solution with no moving parts. 
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Structured illumination microscopy has been shown to perform equivalently (and at 
times better) than confocal microscopy with respect to optical sectioning and SNR, 
particularly in superficial tissues [83-85].  Disadvantages of structured illumination 
microscopy include 1) the amplification of shot noise from the out-of-focus background, 
2) the reduction of recovered signal when the illumination frequency is near the cut-off 
frequency of the imaging optics [86], which can reduce the image quality compared to 
confocal, and 3) its reduced performance in deep imaging as compared to confocal [83].  
However the advantages of structured illumination microscopy in terms of imaging 
throughput and reduced complexity may outweigh the disadvantages in imaging 
performance when the superficial surface of large areas of tissue are to be scanned 
(average breast margin size, 20 cm2 [66]). 
1.7 Objectives 
The first objective of this dissertation was to demonstrate the feasibility of 
designing a low cost, compact optical spectral imaging system for quantitative imaging 
of tissue optical properties in the visible spectral range that directly addresses the above 
limitations of our previously developed clinical system.  A new prototype system was 
designed and constructed with significant reductions to cost and physical footprint.  The 
system was thoroughly tested on a set of tissue mimicking phantoms. 
The second objective was to design and optimize a SIM imaging system with the 
requisite parameters to image tumor margins. Specifically, these included the ability to 
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image fresh tissue immediately after removal from the subject, with sufficient lateral 
resolution (at least 4 µm) and optical section thickness (50-100 µm) that effectively 
reduces out-of-focus fluorescence to isolate single nuclei, and a field of view which may 
be reasonably scaled to cover a large tumor margin.  The system was fully characterized 
on a set of custom-design imaging phantoms with various optical properties. 
In the third objective, the SIM imaging system was applied towards the imaging 
of tumor margins in a transgenic sarcoma model. Additionally, an advanced image 
processing algorithm known as maximally stable extremal regions (MSER) was 
optimized and used to segment nuclei in images acquired with the SIM system and a 
logistic regression model was used for classification.  The results of this study 
demonstrate that the SIM system, in conjunction with proper nuclei segmentation 
algorithms, is capable of effectively differentiating positive from negative tumor sites, as 
well as whole positive from negative tumor margins. 
In short, the three specific aims of this dissertation are as follows: 
Specific Aim 1 – Develop and test a clinically feasible quantitative spectral imaging 
system for imaging of tumor margin morphology 
Specific Aim 2 – Develop and characterize a benchtop non-contact high resolution 
optical sectioning microscope optimized for probing tumor microscopic morphology. 
Specific Aim 3 – To evaluate the diagnostic capability and clinical potential of the 
system in a pre-clinical study using a transgenic mouse sarcoma model
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2. Improvements to the DRS imaging system 
In the following chapter, I present the work related to accomplishing specific aim 
1 of the dissertation.  Significant design changes were proposed and implemented to the 
clinical DRS imaging system.  These modifications were made primarily to decrease the 
cost and size of the system to increase the clinical viability and accessibility. 
2.1 Methods 
2.1.1 System Design 
Figure 4B and 1C show a schematic of the proof-of-concept compact optical 
spectral imaging system and the tip of the spectral imaging system that comes in contact 
with the tissue. Briefly, the design changes implemented in the compact optical spectral 
imaging system (Figure 4B) involved replacing the spectrograph in the clinical system 
with a simple 8-slot filter wheel on the illumination end.  Instead of a 2D CCD, silicon 
photodiodes were used for detection by multiplexing the previous single-pixel design 
reported in the publication by Lo et al. into a 9-pixel 3x3 matrix [87].  The light source for 
the compact optical spectral imaging system is a broadband 350-Watt Xenon arc lamp 
(MAX-302, Asahi Spectra).  Light from the Xenon arc lamp was immediately passed 
through one of eight bandpass filters selected using an 8-slot filter wheel.  The resulting 
monochromatic light was launched into a bundle of 9 optical fibers, each 0.6 mm in 
diameter (FVP600660710, Polymicro), which deliver the light to the tissue through the 
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centered aperture of each of the nine 5.8 x 5.8 mm silicon photodiodes (S1227-66BR, 
Hamamatsu) at the distal end of the imaging probe (Figure 4C).  
Simultaneous measurements of the diffusely reflected light from all 9 fiber-
photodiode pairs can be collected by placing the probe on the surface of the sample.  The 
photocurrent generated by each of the 9 photodiodes was read using a multi-channel 
transimpedance amplifier (Multiboard, SolGel Technologies GmbH) so that the signal 
from each photodiode could be read simultaneously.  The transimpedance amplifier 
circuitry was assembled within a small metal housing and powered using a commercial 
± 12V power supply.  The output voltage (photocurrent converted to voltage via 
transimpedance amplifier) was read and transmitted to a laptop computer using a USB 
controlled data acquisition card (NI USB-6210, National Instruments). 
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Figure 4: Overview of the two spectral imaging systems. A) A system 
schematic of the current clinical spectral imaging system.  This figure contains a block 
diagram of the system as well as a detailed diagram of the probe tip. B) A system 
schematic of the compact optical spectral imaging system which details the 
illumination and collection setup. C) Photograph of the tip of the 3x3 photodiode 
array.  The numbers represent the pixel numbers, which will be referred to 
throughout the manuscript. 
Spectral measurements were accomplished by cycling through each of the eight 
bandpass filters and recording individual measurements at each wavelength rather than 
recording a full spectrum as was done with the clinical system.  In the end, the collected 
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data comprised of an 8 wavelength spectral measurement from each of the nine pixels.  
The impact of measurements at a reduced number of wavelengths on the extraction of 
optical properties was previously addressed and investigated by Lo et al [87].  It was 
demonstrated, through phantom experiments and simulations, that using as few as 5 to 
8 discrete wavelengths with a FWHM bandwidth of 20 nm was adequate for extracting 
absorption and scattering properties of phantoms containing polystyrene spheres and 
hemoglobin.  The same methodology was used to identify eight specific wavelengths 
between 400 and 600 nm (specifically, 400, 420, 440, 470, 500, 530, 570, and 600 nm) each 
with a band pass FWHM bandwidth of 10 nm.  Filters with these specifications (XBPA, 
Asahi Spectra) were inserted into the 8-slot filter wheel. 
In order to facilitate a seamless interface between all the system components 
(Xenon light source, filter wheel, multi-channel transimpedance amplifier, and DAQ 
card), a custom LabView GUI was written and executed on the laptop computer.  The 
program was responsible for synchronizing and controlling all system components and 
storing all collected spectra, analyzed later for extraction of optical properties. 
2.1.2 Theoretical System Characterization: 
 Monte Carlo simulations were carried out to evaluate the system sensing depth 
and to compare it to that of the clinical system. The sensing depth is a parameter heavily 
dependent on the probe geometry and optical properties of the sample.  To estimate the 
sensing depth, a full Monte Carlo simulation was performed for the illumination-
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collection geometry of a single pixel of the compact spectral imaging system and a 
similar approach was used to obtain the sensing depth of a single channel of the current 
clinical system.  Investigating the sensing depth of a single pixel provides a valid 
estimate for all 9 pixels of the probe since they all have an identical illumination and 
collection geometry.  In the Monte Carlo simulation, the path of each collected photon 
was individually tracked, and the deepest point reached in media of each photon was 
recorded.  Initial photon positions were determined by a spatially random uniform 
distribution over a circular region with a diameter equal to the illumination fiber 
diameter (600 µm).  Photons were propagated through the media characterized by a 
given set of optical properties.  Photons were detected if they escaped the surface of the 
media within a square region defined by the dimensions of the photodiode (5.8 x 5.8 
mm) and also within the collecting numerical aperture (NA = 0.96) of the photodiode 
(excluding the circular region occupied by the illumination fiber).  In Monte Carlo 
simulations, each photon was assigned a weight of 1 from the point of launch into the 
tissue.  The weight was successively decreased after each scattering event, and the final 
exit weight of the photon was recorded for all successfully collected photons.  In 
addition, the deepest axial depth which the photon traveled to was also recorded.  The 
total collected weight of all collected photons was calculated by summing the weights of 
all collected.  Finally the sensing depth was calculated by finding the exact depth at 
which 90% of the total collected weight was attained.  The sensing depth was heavily 
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dependent on the optical properties chosen for the Monte Carlo simulations.  These 
optical properties were chosen based on clinically measured optical properties of ex vivo 
breast lumpectomy specimens.  In our clinical measurements, the following three 
different tissue types were encountered (verified by pathology): malignant, normal 
adipose, and normal fibro-glandular whose median optical properties are documented 
in Table 2.  The reported sensing depth was simulated for all three tissue types at two 
wavelengths, 450 nm and 600 nm.  These two wavelengths were chosen to estimate 
shallow and deep sensing depths (450 nm was the shortest wavelength used in the 
clinical system and 600 nm was the longest).  Although 450 nm was not actually used in 
the compact optical spectral imaging system, the purpose of these simulations was to 
enable a direct comparison between the two systems, the only difference being the probe 
geometry.  Therefore, a total of 6 sensing depths for each instrument were reported (2 
wavelengths x 3 tissue types). 
Table 2: The median (over all measured samples) optical properties of three 
different tissue types encountered in our clinical studies.  The number of samples 
measured of each tissue type are also shown.  These optical properties are reported 
specifically for the shortest (450 nm) and longest (600 nm) wavelengths acquired in 
the clinical data. 
 Tissue Type 
Optical Properties 
Malignant 
(n = 10) 
Adipose 
(n = 323) 
Fibro-
Glandular 
(n = 24) 
Absorption Coefficient 
µa (cm-1) 
450 nm 20.34 11.29 10.50 
600 nm 1.42 0.55 0.92 
Reduced Scattering Coefficient 
µs’ (cm-1) 
450 nm 9.55 7.44 13.01 
600 nm 8.47 6.45 11.28 
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Another important parameter which was assessed using Monte Carlo 
simulations was the cross-talk between adjacent pixels.  For optical property extractions, 
each pixel was treated as an individual illumination and collection pair.  Any diffusely 
scattered light collected which originated from an adjacent pixel’s illumination fiber was 
considered cross-talk. Monte Carlo simulations were used to quantitatively assess the 
amount of cross-talk a pixel would receive from an adjacent pixel’s illumination fiber.  
To simulate the cross talk, the collection area was defined by the size of the active area 
for a given pixel (5.8 x 5.8 mm square).  For the illumination area, in addition to 
launching photons from the location of the pixel’s central illumination fiber, they were 
launched from the location of adjacent pixels’ illumination fiber (assuming 8 mm center-
to-center pixel spacing).  With this illumination-collection geometry, and given a set of 
optical properties, we simulated the amount of cross-talk due to photons arriving from 
adjacent pixels.  Cross-talk was simulated for the central pixel (#5) because this 
represented the worst case scenario as it is surrounded by 8 adjacent pixels.  Again, the 
simulations were performed using the optical properties of the three tissue types 
encountered in our clinical studies (Table 2) but this time only at 600 nm.  This was the 
only wavelength chosen for this simulation since absorption is at its lowest, which is 
considered the worst case scenario for cross-talk.  Cross-talk was calculated in a similar 
manner for the clinical system for the purposes of comparison.  The illumination area, 
collection area, and center-to-center pixel spacing were set based on the probe 
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specifications of the clinical system.  However, since the 8 channels of the clinical system 
are arranged in a 2x4 configuration, the pixel experiencing the worst case scenario for 
cross-talk only had 5 adjacent pixels.  The final value of cross-talk was reported as a 
percentage by dividing the number of cross-talk photons by the number of signal 
photons. 
2.1.3 Experimental System Characterization 
Experimental measurements were required to fully characterize the system.  The 
signal-to-noise ratio (SNR) was an important metric to quantify the precision of the 
experimental measurements.  In order to measure the SNR, a liquid phantom was 
constructed with known optical properties (wavelength-averaged µa = 7.00 cm-1 and µs’ = 
14.84 cm-1).  The imaging probe was placed at the surface of the phantom and 15 
repeated measurements were collected.  The SNR was calculated by taking the mean 
and dividing by the standard deviation of these measurements.  This SNR measurement 
from the compact spectral imaging system was compared to the previously measured 
SNR by Lo et al. [87].  The SNR reported in that study was measured on a benchtop 
diffuse reflectance spectroscopy system with instrumentation identical to the clinical 
spectral imaging system.  The SNR measurement with that system on a liquid phantom 
with similar optical properties (wavelength-averaged µa = 7.50 cm-1 and µs’ = 16.00 cm-1) 
provided a sufficient benchmark for comparison for the compact spectral imaging 
system. 
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The overall drift of the system was also measured in order to determine any 
change in system measurement over a period of time.  The probe was placed on a 
Spectralon 99% reflectance standard (SRS-99-010, Labsphere Inc) and diffuse reflectance 
measurements were recorded every 5 minutes over a span of 40 minutes.  The entire 
system (including the probe) was not adjusted or modified during the course of the 
experiment so changes in measurements strictly represented drift caused by the system.   
The drift was quantified by dividing the range by the mean of the measurements 
acquired over this time window.  This ratio yielded a percentage that represented the 
drift of each pixel of the system over the 40-minute period.  The drift measurements 
were taken with both the compact optical spectral imaging system and the clinical 
system to compare the two systems. 
To test the optical property extraction accuracy and robustness of the compact 
optical spectral imaging system, a tissue mimicking phantom study was designed.  The 
liquid phantoms consisted of hemoglobin (H0267, Sigma Co.) as the absorber and 
polystyrene spheres (07310-15, Polysciences, Inc.) as the scatterer.  Hemoglobin was 
chosen due to its distinct absorption spectral features and biological significance in 
tissue measurements.  
The exact wavelength-dependent absorption coefficients (µa) of hemoglobin were 
determined using a spectrophotometer (Cary 300, Varian).   Polystyrene spheres were 
used due to their well-defined size and density, meaning the reduced scattering 
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coefficient (µs’) could be accurately estimated using Mie Theory.  Prahl’s Mie scattering 
program was used to perform this task, using the manufacturer’s specified sphere 
diameter (1.025 µm), density (2.62%), and refractive index (1.6) [88].  With knowledge of 
the optical properties of the constituents, the liquid phantoms could be constructed with 
the desired optical properties by varying the absorber and scatterer concentrations.   
Table 3 documents the expected optical properties of the 14 phantoms made for this 
phantom study, constructed using hemoglobin and polystyrene spheres.  The optical 
property range (µa and µs’) was chosen to match those of the previous phantom studies 
used to characterize the clinical system to enable a direct comparison between the 
accuracy of the two systems [89]. 
Table 3:  Table detailing the optical properties of 14 liquid phantoms (average 
value over 400-600 nm) used to test the optical property extraction accuracy of the 3x3 
compact optical spectral imaging system. The highlighted phantom was used as the 
reference phantom for the inversions using the scalable Monte Carlo model. 
Phantom # 1 2 3 4 5 6 7 
µa (cm-1) 0.50 1.00 1.50 2.00 2.50 3.00 3.50 
µs’ (cm-1) 20.53 20.09 19.66 19.22 18.78 18.34 17.91 
[Hb] (µM) 2.28 4.57 6.85 9.14 11.42 13.71 15.99 
Phantom # 8 9 10 11 12 13 14 
µa (cm-1) 4.00 4.50 5.00 5.50 6.00 6.50 7.00 
µs’ (cm-1) 17.47 17.03 16.59 16.15 15.72 15.28 14.84 
[Hb] (µM) 18.28 20.56 22.84 25.13 27.41 29.70 31.98 
 
To measure the diffuse reflectance of each of these phantoms, the probe tip was 
placed flush in contact with the surface of the liquid phantom.  The liquid phantom was 
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created in a container with dimensions of 11 x 7 x 1.6 cm.  Its length and width were 
large enough to accommodate the entire face of the distal end of the probe.  The depth of 
the phantom was sufficiently large enough to simulate a semi-infinite media (roughly 8 
times the simulated sensing depth).  The liquid phantom was continuously stirred using 
a magnetic stir bar over the course of the phantom study to ensure homogeneity.  Light 
at each wavelength was successively launched into the illumination fibers and the 
diffuse reflected light signal was measured with all nine photodiodes.  A separate 
calibration measurement was taken, after all the phantom measurements, on a 
Spectralon 99% reflectance standard (SRS-99-010, Labsphere Inc.) with the same 
measurement procedure. The collected spectrum of liquid phantom was divided by that 
of the reflectance standard to obtain the calibrated diffuse reflectance spectrum, 
correcting for wavelength-dependent instrument throughput and the spectral shape of 
the source.  
2.1.4 Monte Carlo Model of Diffuse Reflectance 
The collected diffuse reflectance spectrum was processed using a fast scalable 
inverse Monte Carlo model previously developed by our group [26-27].  Our model can 
quickly generate optical properties (µa and µs’) for a given wavelength-dependent 
diffuse reflectance and specific probe geometry [50].  Previous studies demonstrating the 
extraction accuracy and robustness of the model have been reported [51-54]. 
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The forward Monte Carlo model assumes the measured diffuse reflectance spectrum is 
dependent on the two optical properties, absorption (µa) and reduced scattering 
coefficients (µs’).  The absorption coefficient is a function of the wavelength-dependent 
molar extinction coefficient of the absorber and its concentration.  The reduced 
scattering coefficient is described using Mie Theory and is dependent on the size and 
density of the scatterer. In the inverse Monte Carlo model, an initial guess of the 
absorber concentration, scatterer size and density is input into the forward model, 
producing a modeled diffuse reflectance spectrum.  These guesses for the optical 
properties are iteratively updated until the residual sum of squared errors between the 
experimentally measured and Monte Carlo modeled diffuse reflectance is minimized.  
The final optical properties that generate the modeled spectrum which most closely 
matches the measured spectrum are designated as the extracted values. 
2.2 Results 
The compact spectral imaging system was assembled and constructed according 
to the desired specifications listed in the previous section.  With the exception of pixel 8, 
all pixels appeared to be functional once construction was completed.  Unfortunately, 
the central illumination fiber for pixel 8 was broken during assembly.  The individual 
illumination fiber was already permanently fixed in the center of the detector and 
bundled with the remaining illumination fibers.  While polishing the proximal end of 
the illumination bundle, the illumination fiber snapped and separated in the middle 
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resulting in no optical output from pixel 8.  Replacing the individual illumination fiber 
at this stage was not possible, so data was not measured or presented for pixel 8.  The 
results of our simulation and experimental system analysis for the remaining pixels of 
the compact optical spectral imaging system are presented below. 
Figure 5A shows a photograph of the compact optical spectral imaging system 
alongside the clinical system in Figure 5B.  Scale bars are displayed to show the 
reduction in footprint between the new and original systems. Both the size and cost of 
the compact optical spectral imaging system were significantly reduced compared to the 
clinical system. More importantly, the compact optical spectral imaging system can be 
more easily expanded to a larger and denser imaging array with mature semiconductor 
technology. The key physical parameters of the compact optical spectral imaging system 
were compared to those of the clinical spectral imaging system, as shown in Figure 5 
 
Figure 5:  System photographs to compare physical size A) Photograph of the 
modified 3x3 compact optical spectral  imaging system compared to the B) Photograph 
of the clinical system.  The same laptop is pictured in both system photographs in 
order to compare system scale 
25 cm10 cm
A B
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2.2.1 Theoretical Characterization Results 
The results of the sensing depth simulations are shown in Table 4.  The reported 
value (in mm) is a range since sensing depth was calculated at the clinical system’s 
shortest wavelength (450 nm) and the longest wavelength (600 nm).  The comparison 
between the clinical system and compact optical spectral imaging system show that the 
sensing depths are very similar.  In addition, the probe of the compact optical spectral 
imaging system appears to surpass the minimum criterion of 2 mm for a clear margin. 
Table 4:  Side-by-side comparison of key physical system parameters between 
the clinical system and compact optical spectral imaging system.  A noteworthy 
comparison is the large reduction of footprint in the compact system. 
Spectral 
Imaging 
System 
Probe Geometry 
(One Channel) 
Number 
of 
Channel
s 
Center-to-
Center Distance 
Between 
Channels (mm) 
Footprint of 
Entire System  
(L x W x H) (m) Illumination Collection 
Clinical 
System 
19, 0.2 mm 
diameter 
fibers 
4, 0.2 mm 
diameter 
fibers 
8 10 2 x 1.5 x 1 
Compact 
System 
0.6 mm 
diameter 
fiber 
5.8 x 5.8 mm 
Si PD 
9 8 0.35 x 0.3 x 0.2 
 
The cross-talk simulations were also carried out according to the methods 
described earlier. The results of these simulations are shown in Table 5 as well and as 
can be seen, the cross-talk in all three tissue types is significantly smaller in the clinical 
system than the compact spectral imaging system.  A higher cross talk is certainly 
expected for the compact system, considering the collection area of each pixel in the 
compact spectral imaging system (5.8 x 5.8 mm = 33.6 mm2) is much larger than each 
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pixel in the clinical system (4 x 0.2 mm diameter fibers = 0.125 mm2) and more 
importantly, the number of adjacent pixels were 8 in the compact spectral imaging 
system as opposed to 5 in the clinical system (due to differences in system 
configuration).  In addition, the center-to-center pixel spacing is closer in the compact 
spectral imaging system (8 mm) than the clinical system (10 mm) which would also lead 
to increased cross-talk.  However, the results of the tissue mimicking phantom study 
(presented later in this section) demonstrate that this level of cross-talk between pixels 
did not significantly impact the ability to quantitatively extract optical properties. 
Table 5:  Comparison of the simulated sensing depth and cross-talk between 
the clinical system and the compact optical spectral imaging system. The sensing 
depth was simulated at two wavelengths, 450 nm and 600 nm, while cross-talk was 
only simulated at 600 nm. 
System Tissue type 
Sensing depth (mm) Cross-talk encountered by pixel 
surrounded by most adjacent pixels (%) 450 nm 600 nm 
Clinical 
System 
Malignant 0.5 1.5 0.025 
Adipose 0.7 2.2 0.49 
Fibro-Glandular 0.6 1.5 0.031 
Compact 
System 
Malignant 0.6 1.9 1.84 
Adipose 0.9 2.6 9.26 
Fibro-Glandular  0.7 1.9 1.76 
 
2.2.2 Experimental Characterization Results 
The SNR was measured on a highly absorbing liquid phantom with optical 
properties of µa = 7.00 cm-1 and µs’ = 14.84 cm-1.  Measurements were taken and the SNR 
was calculated at each of the eight wavelengths following the procedure described in the 
methods section.  The SNR is shown in Figure 6A, along with the optical power 
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(measured at 400 nm) at the tip of each illumination fiber in Figure 6B.  As previously 
mentioned, data could not be collected from pixel 8 due to a broken illumination fiber.  
The minimum SNR was about 40 dB (at 400 nm) and the maximum was approximately 
65 dB (at 600 nm).  The SNR for each pixel at 400 nm illumination was comparable to the 
32 dB SNR (measured at 405 nm) of the clinical system [87].  The discrepancy of the 
optical power among pixels (Fig. 3B) is due to the packaging of the 9 illumination fibers 
on the proximal end (lamp side).  Light from the Xenon lamp could not couple 
uniformly into all illumination fibers, causing the differences in optical output at the 
distal end.  Although the output power of pixel 9 was noticeable lower, no physical 
defects in the fiber or photodiode were visible. 
Another performance metric which was measured was the long-term drift of the 
system.  The system drift over 40 minutes was approximately ±2% for the compact 
optical spectral imaging system and ±3% for the clinical system.   
 
Figure 6: A) Signal-to-noise ratio (SNR) for all pixels at three different 
wavelengths (400, 500, 600 nm). The SNR was calculated by taking 15 repeated 
measurements on a liquid phantom and dividing the mean by the standard deviation.  
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The optical properties of the phantom used in the SNR measurements were µa = 7.00 
cm-1 and µs’ = 14.84 cm-1. B) The table on the right indicates the optical power output 
(at 400 nm) from the illumination fiber of each pixel. 
The set of 14 liquid phantoms described earlier were constructed and their 
diffuse reflectance spectra were measured using the compact optical spectral imaging 
system.  The acquisition time for a single wavelength was approximately 0.5 seconds 
and approximately 1 second to switch between wavelengths.  Data was collected 
simultaneously from all pixels.  Therefore, approximately 12 seconds was required to 
collect the reflectance spectra from a single phantom.  Figure 7A shows a comparison 
between the diffuse reflectance spectra measured with the clinical system and each pixel 
of the compact optical spectral imaging system.  The spectra displayed are from 
phantom #14 and calibrated to a reflectance standard and reference phantom (#4).  
Overall there is reasonable agreement of the measured spectra between the clinical and 
compact optical spectral imaging systems.  However, pixel #7 does show considerable 
deviation from all other measurements, particularly at the shorter wavelengths (400 and 
420 nm).  
  34
 
Figure 7:  A) Normalized (to reflectance value at 600 nm) diffuse reflectance 
spectrum collected from phantom 14 using the clinical and compact optical spectral 
imaging systems, corrected with a reflectance standard and reference phantom.  The 
plots demonstrated reasonable agreement between the two systems. B) Measured and 
modeled diffuse reflectance spectra from the compact optical spectral imaging system.  
These spectra are not normalized but are corrected with a reflectance standard. 
Examples of the experimentally measured spectrum and final Monte Carlo 
modeled spectrum for two representative pixels (#5 and #7) are shown in Figure 7B.  
While the measured and modeled spectra are in agreement for pixel #5, a small 
deviation exists between 400-420 nm in pixel #7.  The inability to accurately model the 
spectra stems from the measurement error already described.  We believe that this is 
attributed to a construction defect present in pixel 7.  A close-up photograph of pixel 5 
and 7 are shown in Figure 8, which reveals the defect in the illumination fiber of pixel 7.  
This defect is not present in pixel 5, or in any other pixels (not pictured), leading us to 
strongly believe this was the cause of the variation seen in pixel 7.  While our robust 
Monte Carlo model is capable of accounting for different probe geometries, one 
requirement is that light exiting the illumination area must maintain a relatively uniform 
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exit distribution.  However, as the fiber is damaged, the illumination becomes non-
uniform, as seen in the Fig. 5, and the uniformity assumption is compromised. 
 
Figure 8:  Photographs of pixels 5 and 7 demonstrating the physical defect in 
pixel 7.  Note difference in the central illumination fiber in both pixels.  As noted in 
the representative spectra, all pixels match the clinical system aside from pixel #7. 
Ultimately, the performance metric which would determine the viability of the 
system is its ability to quantitatively extract optical properties.  Simply measuring the 
diffuse reflectance would not provide any significant insight into the composition of 
breast tumor margins.  From the final modeled spectra the µa and µs’ values were 
extracted and compared to the known expected optical properties of the liquid 
phantoms using the previously described inverse Monte Carlo model.  One phantom 
(Phantom #4) was also chosen as a reference phantom to put the measured and modeled 
diffuse reflectance on the same scale prior to the inversions.  The choice of this reference 
phantom was based on the comprehensive reference phantom characterization reported 
by Bender et al. [89].  The inverse Monte Carlo model was capable of extracting the 
optical properties of all pixels in <15 seconds.  Figure 9 shows a plot of expected versus 
extracted values for both wavelength-averaged absorption (µa) and reduced scattering 
Pixel 5 Pixel 7
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(µs’) coefficient for all pixels excluding pixel 7 and 8.  These pixels were excluded due to 
their previously mentioned defects and inability to accurate measure and extract optical 
properties.  Each circle on the plot represented the optical properties of one target 
phantom (14 total phantoms) averaged over all wavelengths and all functioning pixels 
(#1-6, 9). 
 
Figure 9:  Plots of the optical property extraction accuracy averaged over pixels 
#1, 2, 3, 4, 5, 6, and 9 of the compact optical spectral imaging system.  The data 
presented is the wavelength averaged µa and µs’ for all 14 liquid phantoms.  Average 
extraction errors for each individual pixel are displayed in following figure. 
The percent error between the extracted optical properties and expected optical 
properties are also calculated and summarized in Figure 10 individually for each pixel.  
A single value for error percentage is reported by averaging over all wavelengths and all 
target phantoms.  Most of the pixels are capable of extracting µa and µs’ with high 
accuracy (<8%).  However, once again pixel 7 is a clear outlier and shows very poor 
extraction accuracy.  This result was anticipated given the previous discussion on the 
physical defect of the pixel.  Overall, the optical property extractions experimentally 
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confirmed the appropriateness of the modeling assumptions, i.e. treating each pixel as 
an independent source-detector pair.  In addition, we demonstrated the feasibility of the 
3x3 photodiode geometry design for acquiring quantitative spectral images.  
 
Figure 10:  Summary of the optical property (µa and µs’ averaged over all 
wavelengths) extraction errors for all pixels.  The errors shown here are the average 
errors over all 14 target phantoms.  Phantom #4 (µa = 2.00 cm-1; µs’ = 19.22 cm-1) was 
used as the reference phantom for the inversions. 
A comparison of all performance metrics between the clinical system and 
compact optical spectral imaging system are summarized in Table 6.  The uncertainty 
reported in the optical property extraction column is the standard deviation of error 
over all pixels (excluding pixel #8) and all phantoms.  It is clear that the performance of 
compact optical spectral imaging system is on par with the clinical system, notably the 
comparison between the µa and µs’ extraction errors compared in Table 6. 
 
 
Pixel 1
µa = 0.78%
µs’ = 7.22%
Pixel 2
µa = 3.70%
µs’ = 3.96%
Pixel 3
µa =  2.43%
µs’ = 5.40%
Pixel 4
µa = 0.99%
µs’ = 5.61%
Pixel 5
µa = 2.76%
µs’ = 2.25%
Pixel 6
µa = 4.69%
µs’ = 2.54%
Pixel 7
µa = 23.33%
µs’ = 59.77%
Pixel 8
No
Inversion
Pixel 9
µa = 12.52%
µs’ = 4.23%
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Table 6:  Comparison of performance metrics between the clinical and compact 
optical spectral imaging systems.  The SNR of the clinical system was measured in a 
previous study (at 405 nm using a phantom with optical properties of µa = 7.5 cm-1 and 
µs’ = 16 cm-1) 
System 
# wavelengths 
between 400-
600 nm 
Drift 
SNR @  
λ = 400 
nm (dB) 
Absorption (µa) and Scattering (µs’) 
Extraction 
Mean µa Error Mean µs’ Error 
Clinical 
System 
81 ±3% 32 9.03% 7.33% 
Compact 
System 
8 ±2% 40 6.04%±7.78% 11.37%±19.62% 
 
2.3 Conclusions 
The major advantage of the compact optical spectral imaging system is the 
significant reductions in both cost and footprint compared to the traditional clinical 
system. These reductions were accomplished by replacing two specific components in 
the current clinical system with simpler, cheaper, and more compact components. 
Rather than using a cooled CCD (20x20x20 cm, ~$20,000), the new system utilized silicon 
photodiodes and appropriate readout circuitry (20x10x15 cm, ~$1000). The second 
component targeted was the grating-based spectrograph (50x50x20 cm, ~$12,000) with a 
filter wheel with 8 slots for band pass filter (20x20x5 cm, ~$900). Replacing these two 
components resulted in over a 10x size reduction and over a 15x cost reduction. 
For the compact optical spectral imaging system design presented here, a Xenon 
arc lamp was used, the same type used in the current clinical systems. With 
experimental proof of our 8 wavelength system, most of the broad spectral output of the 
Xenon lamp is not needed. Alternatively, multiple low-cost discrete wavelength light 
  39
sources, such as light-emitting diodes (LEDs), could replace the Xenon arc lamp. LEDs 
are available in various visible wavelengths, and are considerably cheaper and smaller 
than an arc lamp. This modification would have the potential of further decreasing the 
foot print of the system. 
In addition to replacing the light source, other light delivery strategies can also 
be explored. For the probe presented here, optical fibers are still required for delivery of 
illumination light. However, optical fibers are fragile and cumbersome, important 
limitations for clinical use. Individually fixing an optical fiber in the center of each 
photodiode is a cumbersome procedure, particularly when considering a larger pixel 
array. One possible strategy for light delivery would be to use a robust large aperture 
fiber bundle which would terminate a short distance behind the photodiode array, 
rather than breaking into individual fibers for each pixel. Light exiting from the fiber 
bundle would travel through free space and pass through the holes drilled in the 
photodiode detectors. If LEDs are used, then the LEDs themselves may be fixed behind 
the photodiode array, completely eliminating any optical fibers at the tissue interface. 
These strategies are analogous to shining a flashlight through a mask, although the 
actual implementation requires further investigation. 
One area of interest is to further explore the imaging aspect of our system. While 
exploring the system’s imaging capabilities, the spatial resolution is a natural parameter 
of interest. The spatial resolution of our system is equivalent to the pixel spacing, so in 
  40
this particular probe design, ~8 mm. The pixel spacing defines the relative spatial 
location of each measurement with respect to each other. When reconstructing an image, 
each region of optical properties will be spaced according to this distance. In order to 
improve the spatial resolution, the probe would be redesigned with smaller pixel 
spacing. However, this would not be possible using the same 5.8 x 5.8 mm photodiodes 
used in this chapter. As the photograph of the probe tip in Figure 4C shows, the 
photodiodes are already packed as close as physically possible. Increasing the number of 
pixels or pixel density in the imaging probe could be implemented simply by increasing 
the number of silicon photodiodes or using smaller photodiodes, respectively. 
Undoubtedly, this would increase the spatial resolution of the system, but may impact 
other important system parameters. Moving each pixel closer together may result in 
increased cross talk. One possible solution would be to use an alternated illumination 
pattern (i.e. take two separate measurements and light every other pixel, so the effective 
cross-talk distance is twice the pixel distance). Cross-talk may also be used to our 
advantage, as with greater cross-talk the measurements become an image reconstruction 
problem. This problem is similar to the one faced in the heavily researched field of 
Diffuse Optical Tomography (DOT), where a volume of optical properties is 
reconstructed from reflectance collected from multiple source and detector pairs. 
Analyzing reflectance data collected with our compact spectral imaging system using a 
DOT algorithm is certainly feasible and would address cross-talk issues. Reducing pixel 
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size can also impact sensing depth. Larger sensing depths could be achieved by using a 
ring shaped detector with an inner radius slightly larger than the illumination radius, 
resulting in a ring of “dead area” between the illumination and collection area. This 
would alter the source-detector separation distance and allow deeper penetrating light 
to be collected. 
The compact optical spectral imaging system presented here experimentally 
demonstrates progress towards developing a clinically viable spectral imaging system 
for breast tumor margin assessment. Our group has demonstrated that our scalable 
Monte Carlo model is capable of quantitatively imaging and extracting optical 
properties, which contain valuable information on tissue composition which is 
significant in discerning malignant from benign breast tissue. While these measurements 
can be acquired using our current clinical system, redesigning the system as described in 
this manuscript could increase the widespread clinical viability of quantitative spectral 
imaging through increased portability and speed and decreased cost. 
The compact optical spectral imaging system presented here experimentally 
demonstrates progress towards developing a clinically viable spectral imaging system 
for breast tumor margin assessment based upon using silicon photodiodes for photon 
collection.  While the utility of this system was demonstrated in only liquid phantoms an 
ongoing project is focused on completing the clinical translation.  In collaboration with 
Dr. Nan Jokherst, custom fabricated silicon photodiodes are being manufactured for a 
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clinically robust spectral imaging probe.  With these custom designed and fabricated 
systems, the next step is to move into clinics to test on breast tumor margins. 
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3. Developing a SIM System for Margin Imaging 
Chapter 2 presented a heavily modified DRS system with drastically lower cost 
and footprint.  Despite these improvements to increase clinical viability, there are some 
additional clinical challenges associated with DRS aside from high cost and accessibility.  
In recent clinical studies by our group, it was found that generally β-carotene and µs’ 
were indicative of residual tumor cells on the margin.  However, in certain cases, this 
ratio indicated a region was at risk, however post-pathological analysis revealed the 
corresponding tissue was benign fibrous glandular tissue.  An example of a false 
positive is shown in Figure 11. 
 
Figure 11:  An example of a DRS image acquired with a clinical system on 
human lumpectomy specimen.  Based on the β-carotene to µs’ ratio, sites 1 and 2 both 
appear could potentially be malignant sites.  However, as the pathology reveals, only 
site 1 corresponds to malignancy, while site 2 corresponds to normal fibro-glandular 
tissue.  
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With this limitation in mind, we set out to investigate another optical technology 
with a higher spatial resolution capable of resolving changes in tumor micro-
environment.  Fluorescence-based SIM was selected as an approach due to its ability to 
achieve resolutions at the micron scale.  In combination with the proper stain, specific 
tissue structures, such as cell nuclei, can be clearly visualized. 
While SIM has been applied to a wide range of samples, the majority of previous 
publications have focused on imaging of cells in culture or optically clear samples [82, 
85, 90-92].  A few groups have successfully applied this technique on thick biological 
tissues.  Elson et al. [93] demonstrate the effect of optical sectioning in thin slices of 
mouse ear.  Santos et al. [94] used HiLo microscopy, a specialized form of structured 
illumination for optical sectioning, through a fiber bundle microendoscope to image rat 
mucosa ex vivo. More recently, Lim et al. [95] has also utilized HiLo microscopy in the 
hippocampus region of ex vivo rat brain. There have been limited reports of applying 
structured illumination to thick, intact, highly scattering biological samples.  Mazher et 
al. [96] have previously demonstrated structured illumination imaging in a thick tissue-
mimicking phantom. However, their implementation and analysis focused on the 
diffusion regime (mm to cm spatial scales), rather than the diffraction regime, which is 
more relevant to our microscopic imaging application.    
The optical section thickness is dependent on frequency selected for illumination.  
Chasles et al. [83] provided an in-depth theoretical and experimental analysis of the 
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effect of different grid frequencies on axial resolution and compared structured 
illumination microscopy directly to other optical sectioning techniques.  They 
determined that the axial resolution was improved by a factor of 1.5 when using 
structured illumination over conventional widefield microscopy.  Karadaglic et al. [97]   
presented a detailed theoretical analysis showing that the optical sectioning thickness 
could be appropriately estimated using the Stokseth approximation [98] of the optical 
transfer function of a defocussed imaging system. However, this derivation was 
calculated assuming the sample was a thin fluorescent sheet scanned axially in the 
absence of turbidity.  The exact effect of a scattering background on the optical section 
thickness has not been fully explored.  In addition, the modulation depth, which is a 
measurement of the transfer of the illumination pattern contrast to the focal plane, is 
also directly related to the illumination frequency and scattering of the sample.  
Understanding this relationship is vital as the modulation depth has an impact on the 
signal to noise ratio (SNR) of the sectioned image [84] and the optimal illumination 
frequency has to balance a tradeoff between optical section thickness (which is better at  
higher frequencies) vs. modulation depth and SNR which degrades as frequency 
increases. 
In this chapter, I present the design for a SIM system specifically designed for 
imaging surgical margins.  The system was intended to meet the specifications listed in 
Table 7.  Once constructed, the system was tested on a set of tissue mimicking phantoms 
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to measure, resolution, FOV, contrast enhancement, and SNR.  Finally, preclinical 
images of mouse sarcoma were acquired with the system to demonstrate feasibility in a 
biological system. 
Table 7:  Target design specifications for the SIM imaging system. 
 Resolution Field of View 
Background 
Rejection 
Single Image 
Acquisition 
time 
Target Values 
for SIM system 
4 µm 
2.25 mm2 
(1.5x1.5 mm) 
12 dB < 500 ms 
Justification 
Based on 
nuclear size 
from mouse 
sarcoma and 
human breast 
tissue [99] 
Dependent on time 
needed to cover 
whole tumor 
margin 
Based upon 
segmentation 
ability of 
algorithm [80] 
Dependent on 
overall 
required 
imaging time 
 
3.1 Methods 
3.1.1 Structured Illumination Theory 
The implementation of SI involves illuminating a sample using a sinusoidal 
pattern defined by the following equation: 
 Eq. 1 
The quantity m represents the modulation depth (value between 0 and 1), ν 
represents the spatial frequency, and ϕi represents the phase shift of the pattern.  The 
measured image intensity of a sample illuminated by this pattern can be described by 
the following: 
)cos(1),(
ii
xmyxs  
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 Eq. 2 
In this equation, d(x,y) represents the fluorescence emitted from the sample 
which is out of focus, and f(x,y) represents the in-focus fluorescence.  As only the in-
focus fluorescence from the object is modulated by the sinusoidal component of the 
illumination pattern, a proper demodulation method can be applied to extract only this 
information.  The most straightforward and commonly used algorithm relies on square 
law detection to extract and demodulate the in-focus component. 
2
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 Eq. 3 
As the equation shows, the image, which contains only information from the 
focal plane, ISectioned, is calculated by acquiring three separate images (I1, I2, I3) which differ 
only in phase shift (ϕ1 = 0, ϕ2 = 2π/3, ϕ3 = 4π/3).  The resulting sectioned image thus only 
contains the modulated portion of the object, which corresponds to the plane of focus. 
3.1.2 System Design 
In order to achieve comparable performance to the current histopathologic 
methods, the structured illumination microscopy (SIM) system was designed to resolve 
cell nuclei. The cell nuclei diameter seen in our intended pre-clinical model, a mouse 
sarcoma tumor, is in the range of 5-15 µm [100].  Furthermore, human breast cancer 
nuclei sizes are at least 8 µm in diameter [99]. The field of view (FOV) was also an 
important consideration which was determined by both the size of the sample and 
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desired imaging time.  Because of the relatively large sizes of the preclinical mouse 
sarcoma margins (15 mm2) and breast tumor margins (20 cm2 [101]), the system was 
designed with the largest per-frame FOV as possible, while maintaining the required 
lateral resolution  which in our case was 2.5 mm2 (1.58 x 1.58 mm).  AO was chosen as 
the contrast agent in this study because it has been demonstrated to stain nuclei, skeletal 
muscle, and collagenous stroma [67, 77].  While our studies involved imaging samples ex 
vivo, it is worth noting that AO has been approved for use in humans in at least one 
previous study [77].  As an alternative, other non-propidium iodide nuclear markers, 
such as proflavine and acriflavine, have similar staining properties and proflavine, in 
particular, has been deemed safe for human use and is used as a disinfectant for the 
umbilicus. 
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Figure 12: Detailed schematic of the SIM imaging system.  The 𝜆ex peak was 480 
nm and the 𝜆em peak was 520 nm.  The spatial filter diameter was adjusted to allow 
only the 0 and +1 diffraction orders to pass.  An image of group 7 of the USAF 
resolution target acquired by the system is also shown. 
A detailed schematic of the system is shown in Figure 12.  A broadband super 
continuum laser (Fianium SC400) was used to provide illumination for fluorophore 
excitation.  This source was chosen due to its low coherence which mitigated the 
appearance of speckle in the acquired images.  The output from the laser traveled 
through a band-pass filter centered at 480 nm with a bandpass of 20 nm, which 
corresponded to the excitation peak of AO.  This filter can potentially be replaced to 
match the excitation peak of other intra-vital dyes or even intrinsic fluorophores.  The 
filtered beam was then passed through a 6X beam expander and a polarizing beam 
splitter that redirected the light toward an LCoS SLM display chip (Holoeye LCR-720).  
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Following reflection off the SLM chip, the light traveled through a series of 4 lenses, the 
last of which was the microscope objective (Nikon 4x E Plan Fluor, NA = 0.1).  An iris 
placed one focal length after the first lens was used to spatially filter the diffraction 
orders created by the sinusoidal pattern on the SLM.  The iris was aligned on the optical 
axis to only pass the 0 and +1 diffraction orders. Allowing these two diffraction orders to 
pass yielded a sinusoidal pattern at the sample plane, free of undesired higher frequency 
harmonics, which produce sectioning artifacts if allowed to pass to the sample. The 
resulting fluorescence generated by the illumination pattern incident on the sample was 
collected by the objective and imaged onto the CCD (LaVision Imager 3 QE) using a 200 
mm focal length tube lens (Nikon MXA20696). 
3.1.3 System Imaging Parameters Characterization 
Once the system was constructed according to the design specifications above, 
the basic imaging parameters of the microscope were characterized.  For a Nikon 4x 
objective with numerical aperture (NA) of 0.1, the diffraction limited lateral resolution is 
expected to exceed the value needed for visualization of cell nuclei (3.2 µm, based on the 
Rayleigh criterion calculation and emission peak of AO).  The actual lateral resolution of 
the system was measured using a standard 1951 USAF Resolution test target.  The test 
target was placed at the focal plane of the objective with a fluorescence calibration test 
slide underneath (outside of the focal plane).  Uniform excitation light was projected 
onto the sample and fluorescence emitted from a calibration slide through the test target, 
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which was imaged onto the CCD. The smallest resolvable line pair group was deemed 
as the measured lateral resolution of the SIM system.  In addition, the single frame field 
of view (FOV) was also measured using a larger line pair group from the same test 
target.  
Because of the finite pixel number and size of the SLM, a limited number of 
discrete frequencies could be produced for structured illumination.  Using the 
experimentally measured FOV, the value of each discrete spatial frequency (in mm-1) at 
the sample plane (for each pattern generated by the SLM) was determined by imaging 
the fluorescence from a uniform calibration test slide and calculating the Fourier 
Transform of the resulting image. 
3.1.4 Tissue Phantom Preparation 
A set of phantoms was constructed in order to simulate the type of environment 
seen in thick tissue samples stained with AO.  Each phantom consisted of fluorescence 
spheres (Polysciences, Fluoresbrite YG Microspheres) and TiO2 (Sigma, T8141) in a 
polydimethylsiloxane (PDMS) sample (Dow Corning, Slygard 184).  The phantoms were 
constructed in a petri dish with a cover glass window on the bottom (Mattek, P35G-0-14-
C).  The first set of phantoms used a layer of 1-µm diameter fluorescent spheres dried on 
the cover glass to generate an optically thin layer of fluorescence (simulating the 
superficial layer of AO in tissue). A 1 cm layer of PDMS was added behind the 
fluorescent layer with variable concentrations of TiO2 to create three separate phantoms, 
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each with different scattering levels where the reduced scattering coefficients were  µs’ = 
0 cm-1, 10 cm-1, and 20 cm-1.  A quantity of 0, 2.25, and 4.50 grams of TiO2 per gram of 
uncured PDMS was added to the PDMS for each respective scattering level, calculated 
according to a previously published procedure [102]. The TiO2 was thoroughly mixed 
with the PDMS prior to curing.  Finally the phantom was placed in a vacuum chamber 
to draw out all residual air bubbles from the mixing process and also to effectively cure 
the PDMS.  
Another solid phantom was constructed using PDMS, 10-µm diameter 
fluorescent polystyrene spheres and TiO2 spheres. The size of the fluorescent spheres 
was chosen to simulate the size of targets the system was designed to detect (cell nuclei).  
The underlying PDMS and TiO2 layer was mixed to generate a single scattering 
coefficient of 10 cm-1, which is a commonly measured reduced scattering coefficient in 
soft tissues [66, 101]. 
3.1.5 Structured Illumination Characterization 
The phantom consisting of a single layer of 10-µm spheres with a background 
reduced scattering coefficient of 10 cm-1 was used to demonstrate the contrast 
improvement by computing the signal to background in the structured illumination (i.e. 
sectioned) and uniform illumination (i.e., non-sectioned) images.  The contrast ratio was 
quantified by taking the mean fluorescence intensity of a sphere and dividing it by the 
mean intensity of the adjacent background.  Additionally, the 10-µm spheres were 
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representative of typical size cell nuclei both in mouse and human tissue, so this 
phantom was an appropriate biological model for testing the system. 
 
Figure 13: Schematic demonstrating the method used to measure the optical 
sectioning strength of the imaging system.  Also shown is a detailed diagram of the 
structure of the solid phantom used for measurement.  Three separate phantoms were 
creating with increasing levels, µs’ = 0, 10, 20 cm-1. 
A straightforward procedure was used to experimentally determine the effective 
optical section thickness of the SIM system, as illustrated in Figure 13.  The thin 
fluorescent phantoms (single layer of 1 µm spheres) were translated axially toward the 
objective and a sectioned image (using structured illumination) was acquired at each 10 
µm step.  The mean fluorescence intensity from a region of interest (ROI) within the 
sectioned image was plotted against axial depth to determine the section thickness of the 
system.  In addition, the section thickness was measured over a range of illumination 
pattern frequencies, for each of a range of phantoms with different scattering properties. 
In order to verify the experimental optical section thickness measurements, the 
results were compared to predicted theoretical results.  The defocus of the structured 
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illumination pattern has been previously shown to match the Stokseth empirical 
approximation of the optical transfer function [97, 98]. 
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Where I(u) is the optical sectioning axial response,J1 is the Bessel function of the 
first kind, ν is the grid frequency (as shown in Eq. 1), ṽ is the normalized grid frequency, 
λ is the emission wavelength, nsin(α) is the NA of the objective, z is the real axial 
distance, and u is the normalized axial distance.  The Stokseth approximation provided a 
valid theoretical optical section thickness value to verify measured results. 
Identifying the exact relationship between section thickness and illumination 
frequency was only the first step in selecting the appropriate frequency for imaging.  
The modulation depth, m in the previously shown Eq. 1, is a quantity, which represents 
the amplitude of the sinusoidal illumination pattern transferred onto the sample.  The 
importance of the modulation depth becomes apparent after combining Eq. 1 and Eq. 2 
with Eq. 3 which results in the following [84]: 
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As expected, we can see that the resulting signal of the sectioned image, ISectioned, is 
described primarily by the in-focus fluorescence, f(x,y).  However, a coefficient 
dependent on modulation depth, m, appears in this equation and scales f(x,y) 
accordingly.  In addition, modulation depth decreases with frequency because of the 
natural decay in the shape of the incoherent optical transfer function of the objective. 
The following procedure detailed by Hagen et al. [84] was used to measure the 
modulation depth using the three phase shifted structured illumination images (I1, I2, I3): 
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This method can be used to measure the modulation depth, m(x,y) at each pixel 
within a given image.  The median value was chosen to represent the modulation depth 
over a specific ROI in each image, where fluorescent targets were present.  This median 
modulation depth was measured for a range of frequencies (using the same ROI and 
sample location) on the same fluorescent phantoms used to characterize the optical 
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section thickness.  The phantom was simply placed in focus at the sample plane and 
three phase shifted images at multiple illumination frequencies were acquired.   
Because of the direct relationship of modulation depth on recovered signal, and 
the inverse relationship between SNR and modulation depth, an illumination frequency 
yielding both a sufficient modulation depth and optical section thickness must be 
selected. The SNR of a sectioned image is a quantitative measurement of image quality, 
which is directly influenced by modulation depth.   Using the derivations of Hagen et al. 
[84], the following equations were used to calculate the SNR of the uniform and 
sectioned images respectively:  
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Here, IW represents the traditional widefield image that is reconstructed from the 
three phase shifted structured illumination images.  The sectioned image, ISectioned, is 
calculated using Eq. 4.  The modulation depth (introduced in Eq. 1), m, has a direct 
impact on the SNR of the sectioned image as shown in Eq. 8.  Thus, the measurements of 
optical section thickness, modulation depth and corresponding SNR characterized at 
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multiple frequencies, were used to provide insight into selecting a single illumination 
frequency that provided the best trade-off between these parameters.   
3.1.6 Imaging of Tumor Margins in a Primary Mouse Model of Soft 
Tissue Sarcoma 
In order to demonstrate feasibility for imaging tumor margins, the system was 
tested in a primary mouse model of sarcoma. This model, which was also used for 
biological verification in previous margin imaging studies [103], provides a controlled 
environment of spontaneous tumor growth, and serves as an appropriate preclinical test 
bed for our system.  Primary sarcomas were induced by intramuscular injection of mice 
with conditional mutations in oncogenic K-ras or Braf and p53 with an adenovirus 
expressing Cre recombinase as previously described [100, 104].  The tumor was grown to 
approximately 500-700 mm3 and then surgically removed from the animal, then two 
separate imaging protocols were followed.  The first was to establish congruence 
between the morphology imaged by the SIM system and histopathology by imaging 
frozen sections.  The second was to establish the feasibility of using SIM microscopy to 
image margins by examining freshly excised sarcoma tissues.   
Frozen sections were used to demonstrate that the fluorescent staining approach 
was capable of highlighting tissue morphology comparable to traditional H&E stained 
histology slides.  Immediately after removal from the mouse, the excised sarcoma tissue 
was embedded in optimal cutting temperature compound (OTC) and flash frozen in 
liquid nitrogen.  The frozen tissue block was sliced into 50 µm thick sections spaced 50 
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µm apart and placed on a microscope slide.  To prepare the sample for SIM imaging, the 
tissue sections were allowed to thaw (~5 minutes) and a solution of 0.01% AO (mixed 
with water) was applied to stain the tissue.  The stained tissue sections were then 
imaged using the SIM system and then immediately fixed in formalin.  Next, the fixed 
tissue sections were stained with H&E and imaged using a standard bright-field 
microscope.   
For the second protocol, the fresh, intact tumor specimen was stained with a 
0.02% solution of AO immediately after tumor excision.  After ~30 seconds, the tissue 
was thoroughly rinsed with a phosphate-buffered saline solution to remove any excess 
contrast agent.  A coverglass was placed over the stained tumor tissue to create a flat 
surface and images were acquired using the SIM system.  This procedure was repeated 
when imaging normal skeletal muscle tissue excised from the normal contralateral hind 
limb of the mouse.  Multiple sites were imaged from a single mouse to acquire a 
sufficient image dataset for this protocol. 
3.1.7 Quantitative Image Processing 
As previously mentioned, a well-known hallmark of cancer is increased cell 
nuclear density, due to the increased rate of growth in malignant tissue.  To exploit this 
information, a high pass filter (HPF) algorithm was applied to segment and isolate the 
cell nuclei from other features within the image.  Specifically, a Gaussian filter with a 
standard deviation of 20 pixels was convolved with each maximum-intensity 
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normalized image (implemented using MATLAB).  The standard deviation was 
empirically chosen such that a majority of the nuclei were isolated with HPF.  Each pixel 
corresponded to 1.5 µm given the combination of the specific CCD used for detection 
and 4x magnification objective for imaging.  The typical diameter of a cell nucleus is 5-15 
µm, which corresponded to approximately 3-10 pixels.  Then, a threshold value of 0.1 
(10% of the peak intensity) was applied to the output from the HPF, and any pixel that 
was greater than 0.1 was considered part of a nucleus. Next, a connected components 
algorithm, in which connected pixels are assumed to belong to the same cell nucleus, 
was applied to extract the number of cell nuclei from the filtered image. 
The quantitative image processing algorithm was first applied to the images 
acquired in frozen tissue sections.  The goal was to determine the expected nuclear 
density observed in sarcoma tumor tissue.  The frozen tissue sections were well-suited 
for this purpose as they had corresponding and congruent H&E sections, which are 
widely used by pathologists for diagnosis.  Two frozen sections from four different mice 
(N=4) were acquired and processed using the HPF algorithm to isolate and count the 
number of cell nuclei per mm2.  Because of differing tumor sizes, an ROI (350x350 pixels) 
of solid tumor was manually selected in each image.  The average density was 
calculated over all four mice, which was then used as a benchmark when imaging thick 
excised sarcoma tumor margins. 
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However, in contrast to the frozen section samples, background rejection using 
SIM is vital in thick sarcoma margins to reject background fluorescence and the 
illumination frequency is an important factor in determining the tradeoff between 
optical section thickness and modulation depth. Multiple sites (N=5) from a freshly 
excised intact sarcoma tumor harvested from one mouse was imaged at multiple 
frequencies.  The extracted nuclear density from the optically sectioned thick tissue 
images using the HPF algorithm was calculated over a manually selected ROI the same 
size (350x350 pixels) used in the frozen section analysis.  The average nuclear density at 
each illumination frequency was compared to the benchmark nuclear density 
established from frozen section imaging using a Wilcoxon rank-sum test.  For all tests, a 
p value of less than 0.05 was considered to reject the null hypothesis.   Measuring and 
understanding this information provided further justification for selection of a specific 
illumination frequency to optimize the extraction of nuclear density in the tumor margin 
of the genetically engineered mouse model of sarcoma. 
3.2 Results 
3.2.1 Characterization of Imaging Parameters 
The single frame field of view (FOV) and lateral resolution were the first imaging 
parameters measured using a 1951 USAF resolution target.  Using a 4X objective, the 
smallest element on the target (group 7, element 6) corresponding to a lateral resolution 
of 4.4 µm, was clearly resolved, with a single frame field of view (FOV) of 2.06 x 1.56 
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mm (3.21 mm2).  This measured resolution met our previously mentioned design criteria 
both in terms of enabling visualization of individual cell nuclei (in both preclinical 
mouse models and human tissue) as well as the single-frame FOV to allow imaging of 
typically sized sarcoma tumor margins. 
Table 8 shows a complete list of all illumination frequencies that were achieved 
at the sample plane, with the corresponding objective lens. The 4X objective was used in 
the phantom and sarcoma margin imaging studies due to the wider range of higher 
illumination frequencies at which the samples could be imaged. 
 
Table 8:  List of illumination frequencies achieved at the sample plane for two 
different objective lenses 
Objective Absolute Frequency at Sample Plane (mm-1) 
4x (NA = 0.1) 101, 67.0, 50.3, 47.7, 40.7, 31.7, 24.1, 19.6 
2x (NA = 0.1) 25.1, 16.7, 12.5, 10.2 
 
3.2.2 Characterization of Structured Illumination in Phantoms 
Images were first taken on the phantoms consisting of single layer of 10-µm 
diameter fluorescence spheres.  The spheres were embedded in PDMS and Ti02 giving 
the surrounding medium a biologically relevant reduced scattering coefficient value (µs’ 
= 10 cm-1) to introduce background fluorescence.  The resulting images are shown in 
Figure 14, under both uniform illumination and structured illumination.  Each image 
was normalized by dividing each pixel by the maximum intensity within the image.  The 
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images clearly demonstrate the in improvement seen in structured illumination 
compared to uniform illumination.  The specific illumination frequency chosen to 
acquire these images was 31.7 µm.  The contrast ratio was calculated directly in both 
images by manually selecting ROIs for 5 spheres and dividing by a background ROI 
(both indicated in Figure 14).  The contrast ratio was averaged over these five spheres, 
which showed a significant quantitative improvement, 889±58% greater in the sectioned 
image over the uniform image. 
 
Figure 14:  Images of a single layer of 10 µm fluorescent spheres embedded in 
PDMS and TiO2.  The reduced scattering coefficient of the phantom is approximately 
10 cm-1.  Images were taking using a 4x NA = 0.1 objective and an illumination 
frequency of 31.7 mm-1.  The improvement in contrast is clearly seen from the uniform 
to structured illumination image.  The signal-to-background was calculated by taking 
the intensity of 5 manually selected spheres (indicated by red arrows) and dividing by 
the background ROI (indicated by the blue square).  All scale bars are 100 µm 
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The optical sectioning strength for each corresponding illumination frequency 
(from Table 8) was measured using the phantoms and methods described previously 
and also depicted in Figure 13. The optical sectioning thickness decreased as the 
illumination spatial frequency increased, as expected.  The results detailing the 
experimental relationship between optical section thickness and illumination frequency 
are displayed in Figure 15.  The plot on the left shows a single axial scan through one 
phantom (single layer of 1 µm spheres, µs’ = 0 cm-1) using an illumination frequency of 
19.6 mm-1.  The optical section thickness was defined as the distance at which the mean 
intensity dropped to 50% of the intensity at the focal plane.  The plot on the right shows 
the measured optical section thickness in all three phantoms (each with a different 
scattering level) at all available illumination frequencies.  Each of the three phantoms is 
represented with a different symbol.  Overall these results clearly show a non-linear 
relationship between optical section thickness and illumination frequency. Error bars on 
each measurement were generated by selecting eight different regions of interest within 
each image stack and measuring the standard deviation among the optical sectioning 
thickness of all regions.  Statistical analysis of the data using a Student’s t-test 
demonstrated no significant difference between scattering levels. The measured optical 
section thickness data was compared to a theoretical value acquired using the Stokseth 
approximation to the optical transfer function (Eq. 4) described in the Methods section.   
As shown in Figure 15(A) the measured data of the single axial scan matched with 
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Stokseth approximation (using the variables ν = 19.6 mm-1, λ = 520 nm, and NA = 0.1).  
Also shown in Figure 15(B), the measured optical section thicknesses showed excellent 
agreement with the theoretical optical section thickness calculated using the Stokseth 
approximation. 
 
 
Figure 15:  Optical section thickness measurements from solid phantoms. (A) 
Plot of the mean image intensity as a function of distance from focal plane used to 
determine optical section thickness. The circles represent data that was acquired on 
the µs’ = 0 cm-1 phantom using a 4x NA = 0.1 objective with an illumination frequency 
of 19.6 mm-1.  The solid line represents the Stokseth approximation (Eq. 4) calculated 
using the same variables. (B) Plot relating optical section thickness to illumination 
grid frequency for a range of reduced scattering coefficients. The datapoints represent 
the measured values on phantoms, and the solid line represent the theoretical value 
calculated using the Stokseth approximation.  The dotted arrows show how the 
optical section thickness was measured on the left and how it was placed on the 
corresponding plot on the right. 
After determining the frequency dependence of optical section thickness, the 
modulation depth at each illumination frequency was measured using the method 
described by Hagen et al. [84]. The measured modulation depths in two separate 
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phantoms (µs’ = 0 and 10 cm-1) for each frequency are shown in Figure 16.  The 
modulation depth was calculated, as described in the Methods section, over an identical 
ROI in each image for all illumination frequencies using the same laser illumination 
power and CCD integration time.  Error bars were generated by computing the standard 
deviation of modulation depth over 10 images at the same sample location.  The plot 
clearly indicates an inverse relationship between modulation depth and illumination 
frequency.  In addition, a significant decrease in modulation depth at all frequencies is 
seen in the phantom with µs’ = 10 cm-1 compared to the non-scattering phantom. 
 
Figure 16:  Modulation depth as a function of grid frequency for non-scattering 
phantoms and scattering phantoms (two µs’ levels).  The points labeled A and B are 
referenced in the Discussion section. 
Figure 17 shows a plot of the ratio of uniform SNR to sectioned SNR against 
modulation depth (i.e., it represents the reduction in SNR of SIM compared to standard 
widefield microscopy).  As the data demonstrates, the ratio decreases with modulation 
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depth, indicating less degradation in SNR at higher modulation depths compared to lower 
modulation depths. 
 
 
 
Figure 17: SNR ratio (uniform SNR to sectioned SNR) versus modulation 
depth for non-scattering and scattering phantoms.  The points labeled A and B are 
referenced in the Discussion section. 
3.2.3 Demonstration of System in a Mouse Model of Sarcoma 
To demonstrate feasibility of imaging tissue histology with appropriate 
resolution, the system was tested on 50 µm thick frozen tissue sections cut from a 
sarcoma tumor harvested from a primary mouse model of sarcoma.  Representative 
images are shown in Figure 18.  These images demonstrate excellent congruence 
between the morphological images acquired by the SIM system and the H&E 
micrographs.  It is clear from these images that the AO stains both the cell nuclei and 
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skeletal muscle.  Importantly, the features of the H&E image are recapitulated in the AO 
image based on intensity differences: the cell nuclei are more brightly stained than the 
muscle tissue.  The sarcoma tissue can be observed invading into the muscle tissue in 
both the H&E and AO image.  Because these were thin tissue sections, the images did 
not contain a large amount of background fluorescence.  As can be seen, there is not 
substantial image contrast improvement from the uniform to the sectioned image 
(acquired at f = 31.7 mm-1). 
 
Figure 18:  Images of a 50 µm tissue slice demonstrating the correlation 
between images acquired by the SIM system and H&E histological micrograph.  SIM 
images were taking using the 4x objective and a frequency of 31.7 mm-1.  H&E images 
were taken using a 2.5x objective and the images were cropped to match one another.  
Site imaged on tissue contains both cross sectional skeletal muscle (M) and sarcoma 
tumor (T).  The arrows on each image point out a site where tumor tissue was 
invading into the normal skeletal muscle.  Scale bars are 100 µm. 
To demonstrate the feasibility of imaging of thick tissue, freshly excised sarcoma 
tumor tissue was imaged using the SIM system.  Representative images (uniform and 
sectioned) of mouse skeletal muscle are shown in Figure 19(A) and sarcoma tumor in 
Figure 19(B).  Because these tissue samples are intact and non-sectioned a large amount 
of scattered background fluorescence is visible in the uniform illumination images.  As a 
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result, the contrast enhancement provided by structured illumination improves 
visualization of individual muscle fibers in normal tissue and individual cell nuclei in 
tumor tissue.   Both of these tissue sites were imaged with a frequency of 37.1 mm
-1
, 
which resulted in median modulation depths of 0.24 and 0.17 in the muscle and tumor, 
respectively. 
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Figure 19:  Uniform and structured illumination images acquired from mouse 
tissue. (A) Images of skeletal muscle from mouse.  Both longitudinal and cross-
sectional muscle can be seen in the region of interest (B) Image of tumor tissue from 
mouse sarcoma.  Cell nuclei are the only source of contrast apparent in these images.  
Contrast enhancement is clearly seen in the sectioned images (acquired at f = 31.7 mm-
1).  Scale bars are 100 µm. 
3.2.4 Analysis of Images Using a HPF algorithm for Quantification of 
Nuclear Density 
As shown in Figure 19, application of AO as a fluorescence contrast agent 
enabled the SIM system to clearly visualize cell nuclei in both frozen sections and intact 
tissue.  While qualitative differences were seen in these images, a quantitative metric 
such as nuclear density would aid in assessing the effect of illumination frequency on 
the quality of the sectioned image.  As an initial approach, a simple HPF algorithm was 
used to isolate the cell nuclei described in the methods section.  This was first applied to 
a set of eight images acquired from frozen sections of a sarcoma tumor from four 
different mice (two images per mouse).  The samples were specifically selected so that 
pure sarcoma tumor tissue (confirmed by H&E staining) was visible and an ROI 
(350x350 pixels) containing only tumor tissue was manually selected from each image.  
Quantitative analysis of this image set indicated that the average cell nuclei count was 
3561±754 nuclei/mm2 over a single ROI of pure sarcoma tumor tissue averaged across the 
eight images (mean ± standard deviation calculated from different FOVs of sarcoma 
tissue harvested from one animal). 
Next, the HPF quantification algorithm was applied to images of thick in situ 
sarcoma tumor to determine the impact of different illumination frequencies on the 
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quantitation of nuclear density.  Again, the sample was selected to ensure that tumor 
tissue was imaged and the same ROI (350x350 pixels) was imaged using three different 
illumination frequencies (24.1, 31.7, 47.7 mm-1).  The original frozen section (50 µm tissue 
slice), in situ uniform, and in situ sectioned images (only f = 31.7 mm-1 shown) and 
corresponding HPF images are displayed in Figure 20.  These images demonstrated that 
applying HPF to the in situ uniform image was unable to accurately isolate cell nuclei, 
while also applying HPF to the in situ sectioned image isolated more cell nuclei, which 
closely resembled the 50 µm tissue slice. 
 
Figure 20:  Fluorescent images of mouse sarcoma tissue processed using a 
high-pass filter (HPF) algorithm to isolate cell nuclei.  The in situ sectioned image 
(acquired using f = 31.7 mm-1) 
The corresponding sectioned images of sarcoma tissue at each illumination 
frequency are shown in Figure 21(A), which qualitatively show the impact of frequency 
on isolating cell nuclei.  For a quantitative analysis, the mean nuclear density was 
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calculated on a set of five separate images of in situ sarcoma tumor tissue (different 
FOVs of sarcoma tissue harvested from one animal).  This was done on both the uniform 
illumination and sectioned images acquired at three illumination frequencies and a 
comparison to the mean nuclear density from the 50 µm frozen section images are shown 
in Figure 21.  The p-values were calculated using a Wilcoxon rank-sum test, and revealed 
that the in situ density from the uniform illumination images were significantly lower 
(p<0.05) than the quantified density from the 50 µm tissue slice images and the sectioned 
images at all three frequencies.  Specifically, the nuclear density from the uniform 
illumination images was smaller than the density in the tissue slice and sectioned images 
indicating that the lower contrast between nuclei and the background seen in the uniform 
illumination (i.e., non-sectioned) images leads to underestimation of nuclear density. 
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Figure 21:  Results demonstrating the impact of illumination frequency on 
quantification of cell nuclei density. (A) Sectioned images of mouse sarcoma tissue at 
multiple illumination frequencies.  The corresponding HPF processed images are 
shown which demonstrate the isolation of cell nuclei.  (B) Mean density of cell nuclei 
extracted from images mouse sarcoma tissue.  The nuclear density extracted from the 
50 µm thick frozen section images (N=9) was compared to density extracted from in 
situ tissue imaging (N=5), both uniform and sectioned (f = 47.7, 31.7, 24.1 mm-1) 
images. 
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3.3 Discussion 
Structured illumination is an elegant approach to solve the problem of optical 
sectioning in microscopy, essentially analogous to frequency modulation techniques 
used to encode electrical signals.  Structured illumination is a low-complexity solution 
for optical sectioning microscopy of thick tissues that has the potential for clinically 
feasible high throughput microscopy of tumor margins due to its light efficiency and 
parallel-pixel detection approach.  We have presented a custom SIM microscopy system 
with a low magnification, low NA objective designed to maximize the single-frame FOV 
for applications requiring large area tissue surveillance such as is the case for tumor 
margin imaging.  We designed a series of experiments to fully characterize SIM 
performance for tumor margin imaging, and demonstrated that SIM (optical sectioning) 
of thick tissue provides equivalent quantitation of nuclear density, a hallmark of 
carcinogenesis, as compared to frozen section analysis (physical sectioning) using the 
same fluorescent staining approach. 
The choice to use an SLM to generate the structured pattern for illumination 
allowed us to explore the role of frequency in optical sectioning performance in thick, 
turbid samples.  It is generally understood that using a higher illumination frequency 
yields a thinner optical section at the focal plane, leading to greater background rejection 
and enhanced contrast at the focal plane.  While this is a desirable result, the caveat of 
using a higher frequency is a decrease in modulation depth primarily due to the 
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attenuation of higher pattern frequencies by the optical transfer function of the 
illumination optics.  Furthermore, the effect of sample turbidity on optical sectioning 
performance with SIM had not been systematically investigated prior to this work.  As 
demonstrated in Figure 15, regardless of the underlying scattering properties of a 
sample, increasing the illumination frequency yields increasingly thinner optical 
sections (which follow theoretical calculations of attenuation of signal from a thin 
fluorescent sheet with defocus).  However, the decrease in optical section thickness is 
not linear with respect to illumination frequency and actually follows an asymptotic 
relationship.  It has been previously shown that the thinnest optical section that can be 
achieved is using a normalized grid frequency ṽ (ref. Eq 6) equal to 1 [97].  Given the 
specific parameters of our system (NA = 0.1, λ = 520 nm), this would correspond to an 
absolute frequency of 191 mm-1, resulting in an optical section thickness of 36.6 µm.  
Using the Stokseth approximation, 90% of the thinnest optical section (40.6 µm) is 
achieved at a frequency of 132 mm-1.  An additional 10% increase of the optical section 
thickness to 45.7 µm occurs at an illumination frequency of 106 mm-1. In other words, 
increasing the illumination frequency from 106 mm-1 to 191 mm-1 (an 80% increase in 
illumination frequency) only results in a 20% decrease (<10 µm) in optical section 
thickness.  From this data, it is clear that there are diminishing returns when trying to 
achieve a thinner optical section by increasing the frequency. 
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In contrast to the optical section thickness, the modulation depth decreases 
nearly linearly with increasing spatial frequency as shown in Figure 4.  This is important 
because the SNR is directly linked to modulation depth and as Figure 5 demonstrates, 
this relationship is also non-linear.  This indicates that not only is there potentially less 
benefit in increasing the frequency to reduce optical section thickness as the frequency 
cutoff of the optical transfer function is reached, but in doing so it would also 
significantly degrade the SNR of the sectioned image as well.  For example, looking 
specifically at the illumination frequency of 31.7 mm-1, the corresponding optical section 
thickness at this frequency was 129 µm.  If the illumination frequency is increased to 
47.7 mm-1, then the expected optical section thickness would be decreased by 29%.  
However, the SNR would be disproportionally decreased by 217%, assuming that the 
reduced scattering coefficient of the medium, µs’ is 10 cm-1. 
Figure 16 indicates that the achievable modulation depth is also affected by the 
amount of background signal, which underscores the need to measure modulation 
depth in the target tissue before choosing the optimum illumination frequency.  
Additionally, Figure 17 shows that with knowledge of modulation depth, the SNR 
reduction in sectioned images can be estimated. A comparison between two specific data 
points in Figure 6, referred to as point A (illumination frequency = 47.7 mm-1, µs’ = 0 cm-
1) and point B (illumination frequency = 31.7 mm-1, µs’ = 10 cm-1), is instructive.  While 
they have noticeably different illumination frequencies and scattering properties, Figure 
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16 shows that the measured modulation depth of points A and B are actually very 
similar, 0.248 and 0.252, respectively (~2% difference).  And it follows, as no surprise, 
that in Figure 17, the uniform SNR to sectioned SNR ratio for point A and B are 17.5 and 
17.1, respectively, which are also very similar (~2% difference).  Regardless of how a 
particular modulation depth is achieved, either through using a certain illumination 
frequency, altered by scattering background, or the combination of the two, the SNR 
reduction is only dependent on the actual measured modulation depth.    
Finally, the images from pure sarcoma tumor tissue, which were processed using 
the HPF algorithm and shown in Figure 20, demonstrated the value of SIM, as standard 
uniform illumination failed to isolate the majority of cell nuclei and significantly 
underestimated the nuclear density (shown in Figure 21).  Interestingly, the statistical 
analysis also showed that regardless of the three illumination frequency selected, the 
quantified nuclear densities from the optically sectioned images were not statistically 
different from the 50 µm tissue slices.  As a compromise between optical section 
thickness and SNR reduction, the illumination frequency of 31.7 mm-1 was selected for 
this specific system and imaging application.  At this frequency, the expected optical 
section thickness was 129 µm and the median modulation depth over the entire image 
was 0.137.  Although this modulation depth corresponded to a 50-fold reduction in SNR 
from the widefield case, it was clear that this was outweighed by the improved contrast 
with respect to not only visualizing, but also properly segmenting tumor cell nuclei. It is 
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worthwhile to note that this combination of illumination frequency, wavelength, and 
NA yield a normalized frequency (introduced in Eq.4) of ṽ = 0.165.  Previous studies 
have shown that a normalized frequency of ṽ = 1 yields the thinnest possible optical 
section [83, 97].  While this certainly holds true in the case of our system, we determined 
that use of the lower spatial frequency provided sufficient benefit from background 
rejection due to optical sectioning, while still retaining enough signal to identify critical 
structural information in the sectioned images. Future controlled studies on a larger 
cohort of animals will determine the accuracy of using this system to differentiate 
between positive and negative tumor margins. 
The conclusion for illumination frequency choice was intended specifically for 
our system and biological application described in this chapter.  In other applications 
and system configurations, the optimal illumination frequency may be different than the 
one chosen. We note here that although we used a 4X objective in this implementation to 
achieve a desired balance between single-frame field of view and resolution, that the 
resolution could be increased at the expense of single-frame field of view, by going to 
higher power objectives.  Mosaics can be constructed which provide an overall larger 
field of view, and allow the images to be viewed digitally at a range of magnifications 
(larger than the single-frame magnification).  However, our results demonstrated that 
the optical section thickness for a given microscope objective could be accurately 
represented using the Stokseth approximation regardless of the scattering properties of 
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the tissue.  Additionally, the SNR reduction in the sectioned image was only dependent 
on modulation depth and independent of tissue scattering.  While the scattering did 
affect the modulation depth, it can be measured and quantified directly without 
knowing the exact scattering properties of the tissue.  Therefore, optical section thickness 
and SNR reduction can be calculated simply by knowing the objective NA and 
measuring the modulation depth, respectively.  This yields a straightforward approach 
for one to characterize structured illumination and determine the appropriate 
illumination frequency for a specific application. 
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4. Preclinical Validation of the SIM system 
As the results and conclusions from Chapter 3 demonstrate, the SIM system has 
the necessary specifications for imaging tumor margins.  In the following chapter, I 
focus on a study where the SIM system has been applied to a larger cohort of animal.  In 
total, 23 margins were imaged from tumors that were surgically excised from mice.  The 
images were quantitatively analyzed using an algorithm called maximally stable 
extremal regions (MSER) to identify and segment AO-stained regions arising from cell 
nuclei.  Finally, a predictive model was constructed using logistic regression to 
distinguish between tumor and normal tissue sites and ultimately classify whole 
margins as positive or negative. 
4.1 Methods 
4.1.1 Margin Imaging Protocol 
To simulate clinical tumor growth and disease progression, a transgenic sarcoma 
model was selected as a primary testbed for margin classification [100].  Mice with 
conditional mutations in oncogenic K-ras or Braf and p53 were injected intramuscularly 
in their hind leg with an adenovirus expressing Cre recombinase to induce primary 
sarcomas.  The spontaneous nature of this model accurately represented a clinical tumor 
margin compared to a tumor xenograft that would tend to develop a fibrous 
encapsulation. 
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After injection of the adenovirus, the sarcoma tumor was allowed to develop and 
grow to 500-700 mm3 (60-90 days) and then surgically removed from the animal.  To 
simulate clinical treatment, the mouse was anesthetized with isofluorane for the 
duration of the surgical procedure.  During the procedure, the entire leg, including the 
tumor mass, was amputated to expose the relevant margin.  The excised tumor margin 
was immediately prepared for imaging by topically applying a 0.01% aqueous solution 
of AO and then rinsed with 0.1M phosphate-buffered solution (PBS).  To obtain the 
highest quality images, a cover glass was placed on top of the tumor margin to create a 
flat focal plane for imaging. 
A brief overview of the imaging procedure is shown in Figure 22.  The sample 
was placed on a 3-axis translation stage under the imaging objective for the purposes of 
focusing and lateral translation.  Due to the large relative size of the tumor relative to the 
field of view (FOV) of the SIM system, multiple images were acquired to cover entire 
margin.  Beginning at the first image location, the sample was translated to each 
subsequent image location using a micrometer to ensure the sample was moved an 
equal distance between image sites.  A small amount of overlap between adjacent 
images was allowed to ensure the entire margin was imaged.  The sample was moved 
1.7mm in the x-axis and 2.0 mm in the y-axis, with a typical margin fully imaged using 
4-6 sites. 
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Figure 22:  Flowchart demonstrating the imaging protocol immediately after 
the tumor margin was removed from the transgenic sarcoma model.  After the 
procedure above was completed, the tissue sections were inked to identify the area 
imaged, stained with H&E and submitted to pathology. 
To correlate the imaging results obtained with the SIM system to pathology, a 
procedure was carefully followed immediately after imaging.  Tattoo ink was painted 
over the region of the tissue that was imaged, which allowed the pathologist to identify 
the corresponding margin after fixing and slicing the tissue.  After applying ink, the 
tissue was immediately frozen in optimal cutting temperature gel (OCT) using liquid 
nitrogen.  A microtome was used to slice 5 μm thick tissue sections (cross-section to the 
tissue face painted with ink) spaced 500 μm apart.  The tissue sections were then fixed in 
formalin and then stained with H&E.  A pathologist reviewed all slides from a given 
margin to classify it as a positive or negative margin.  The exact number of H&E slides 
varied based on the physical size of the margin.  The criterion used to determine a 
positive margin was to identify the presence of any tumor cells directly in contact with 
ink. 
Surgically resect 
tumor mass from 
animal
Image 
relevant 
margin with 
SIM system
4x Objective
Ink the 
imaged 
margin
3-axis imaging
platform
Fix in formalin 
and slice into
5 µm sections
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4.1.2 Image Processing Algorithm (MSER) 
In order to analyze and assess the images obtained of the sarcoma margins, an 
imaging processing algorithm was optimized and applied to the images in order to 
segment the AO-stained regions with texture arising from cell nuclei.  The goal of the 
analysis was to leverage the specific the increase in nuclear density and changes in 
nuclear shape and size that differentiate positive from negative margins. 
A technique call maximally stable extremal regions (MSER) was used to segment 
specific AO-stained features from a heterogeneous background of muscle and adipose 
tissues [105]. MSER has been used previously in the image processing community for 
automatic reconstruction of 3D scenes, but has also been applied to biomedical 
microscopy in recent studies [106, 107].  A flow chart with an overview of the MSER 
algorithm is shown in Figure 23.  Briefly, MSER utilizes basic intensity thresholding; 
however, no global or optimal threshold is sought, rather all thresholds are tested and 
the stability of the isolated connected components (i.e. nuclei) are evaluated. More 
specifically, all possible thresholds are applied to an image and all sets of connected 
components (adjacent pixels with intensity values that exceed the current threshold) that 
are isolated with each threshold are stored. This yields a data structure in which the area 
of each connected component is stored as a function of the intensity threshold. Finally, 
the intensity thresholds that correspond to a local minimum in the rate of change of the 
area function for each connected component are selected as thresholds producing MSER. 
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Figure 23:  A) Overview of the maximally stable extremal regions (MSER) 
algorithm.  This algorithm, which is used in the automatic reconstruction of 3D scenes 
was selected as it was a more robust approach than a simple global image threshold.  
MSER tests all intensities thresholds within the image to ensure local maxima within 
various background intensities are not lost.  B) A detailed description and visual 
representation of the five variable parameters used in MSER, MinArea, MaxArea, 
Delta, MaxVariation, and MinDiversity. 
4.1.3 MSER Optimization Procedure 
In order to apply MSER specifically to our images, five tuning parameters 
associated with MSER, which are detailed in Figure 23B, needed to be selected. The 
descriptions of all variables are provided in Table 9. The two most straightforward 
parameters are MinArea and MaxArea, which are related to the expected size of the 
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connected components (i.e. nuclei). These parameters were selected based on the 
biologically expected range of nuclear diameters because the goal of applying MSER 
was to segment AO-stained features primarily generated from the cell nuclei.  
Specifically, MaxArea was set to 15 pixels, which corresponds to greater than 20 µm in 
diameter, which is the largest nuclear size for the sarcoma mouse model. MinArea was 
set to 3 pixels, which correspond to less than 5 µm in diameter, which is the smaller 
nuclear size for the sarcoma model. The next set of parameters was related to the 
intensity thresholds and included MaxVariation, MinDiversity, and Delta. These 
intensity parameters were systematically tuned through the range of values seen in 
Table 9 on 30 representative images containing distinct tissue types, 10 tumor, 10 
muscle, and 10 adipose. 
Table 9:  The MSER parameters that are related to intensity.  A short 
description of the function of each parameter and range of values used during the 
optimization procedure is given. 
Parameter Description Range tested 
MinArea Minimum allowed size of connected component 
region.  Selected based on minimum expect nuclei 
size. 
[3] 
(pixels) 
MaxArea Maximum allowed size of connected component 
region. 
Selected based on maximum expect nuclei size. 
[15] 
(pixels) 
MaxVariation Maximum intensity variation allowed within in a 
region 
[0 50] 
(bit-depth) 
MinDiversity When the relative variation of two nested regions is 
< MinDiversity, then only the most stable region is 
selected 
[0 1] 
(relative units) 
Delta Related to the intensity stability of a region of 
connected components. The stability of a region is 
the relative variation of the region area when the 
intensity is changed of ±0.5*Delta. 
[2 50] 
(bit depth) 
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These specific tissue types were chosen due to their common occurrence in the 
original 23 mice margin dataset.  Each image was a region of interest cropped from a 
margin to ensure that only the specified tissue type was present.  The images were 
processed multiple times using the MSER algorithm while slightly varying the 
parameters in each iteration.  The area fraction, segmented area divided by total image 
area, was the metric calculated to compare each subsequent image output.  The method 
for calculating area fraction is shown in Figure 24A. 
 
Figure 24:  Methodology for calculating area fraction of a MSER segmented 
image.  Area fraction was the metric used to quantify the performance of the MSER 
algorithm. 
4.1.4 Tissue Type Classification Model 
To approach this, we developed and optimized a predictive model to distinguish 
between images of distinct tissue types.   A total of 30 images (10 of each tissue type) 
were manually selected as a training dataset for constructing this site level-predictive 
model.  Each image was a 350x300 pixel region of interest (ROI) from the original dataset 
of 23 margins.  These smaller ROIs were selected to ensure that each   This ROI size was 
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chosen because it was roughly equivalent to the FOV of a 10x objective, a typical 
magnification used by pathologists when studying a suspicious region. 
One additional step was taken to further divide each image into smaller elements 
and each image was broken into 42 evenly spaced 50x50 pixel bins.  This procedure is 
shown visually in Figure 25.  The rationale for this step was if classification was carried 
out on the 350x300 pixel ROIs, it is likely that small focal areas of tumor would not be 
detected.  A bin size of 50x50 pixels was chosen because this corresponded to the 
diameter of a single skeletal muscle fiber or a single adipose cell.  After this step, the true 
number of measurements in the training dataset was N=1260 bins (30 images with 42 
bins per image) with N = 420 tumor bins and N = 420 muscle bins, and N = 420 adipose). 
 
Figure 25:  Flow chart which demonstrates the quantitative analysis carried out 
on the site specific ROIs.  The purpose of this analysis was to develop a predictive 
model to differentiate tumor tissue from muscle and adipose.  A total of 30 images 
were used as a training dataset to develop the model.  Each image was further divided 
into smaller bins to ensure very localized disease could be detected.  Finally, three 
quantities were calculated for each bin, area fraction, average diameter, and average 
shape, and used as input variables for a logistic regression model. 
Using the segmentation output from the MSER algorithm, three different 
variables were calculated for each bin, area fraction, average diameter, and average 
Site Specific ROI
N = (10 tumor,10 muscle,10 Adipose)
Grid Analysis
50x50
pixel bins
Calculate:
1) Area Fraction
2) Avg Diameter
3) Avg Shape (Area/Perimeter)
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shape (perimeter/area).  Area fraction was selected as a variable due to the expected 
increased density of AO-stained features (such as cell nuclei)  in tumor tissue over 
normal tissue.  Nuclear diameter was chosen to represent the expected increase in 
nuclear size of tumor cells and shape was selected to identify the pleomorphic nature of 
tumor cells. 
4.1.5 Logistic Regression 
Once area fraction, average diameter, and average shape were quantified for each bin, the 
goal was to construct a predictive classification model to differentiate tumor bins from normal 
bins.  While the training dataset contained three distinct tissue types, a binary logistic regression 
model was chosen for the classification algorithm.  To reduce the three group training dataset to a 
binary dataset, the adipose and muscle tissue were classified together as normal tissue sites. 
Briefly, logistic regression is statistical classification model used to predict a binary 
response given specific variables from a data point.  In this case, the data points corresponded to 
each 50x50 pixel bin (N = 1260) and the binary response corresponded to known classification (1 
= tumor, 0 = normal).  The logistic regression model was implemented using the statistical 
software package R.  The general form of a 3 variable logistic regression model is as follows: 
 ( )                    
Where g(x) is the model predictor value which is a fitted logistic function,    represents 
the model coefficients,    and are the variable values.  In our case,    are the quantified 
variables from each bin which where: 
   – Area Fraction 
   – Average Diameter – average value of all segmented regions contained within the 
grid element 
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   – Average Shape – average value of all segmented regions contained within the grid 
element 
For each bin, these variables, along with the diagnosis (1 for tumor, 0 for muscle or 
adipose), were input into the R logistic regression code which estimated the coefficients   ,   , 
  , and   .  The model predictor value,  ( ), is then calculated for each bin, where a higher 
value corresponds to a higher likelihood of presence of tumor.  Furthermore, the probability 
(between 0 and 100%) a given bin is tumor can be calculated from g(x) using the following 
equation: 
            ( )          
 
     ( )
   
4.2 Results 
4.2.1 Margin Imaging Results 
In total, 23 mice were imaged following the procedure in the Methods section.  In 
addition to imaging with the SIM system, each margin was also diagnosed by a highly 
trained pathologist who specializes in connective tissue pathology.  The specific 
breakdown of mice is shown in Table 10.  From out dataset of 23 total margins, 15 
margins were positive and 8 margins were negative.  It should be noted that Table 10 
also specifies a portion of mice where the tattoo ink was lost during the tissue processing 
and the pathologist was unable to locate any ink in the H&E slides.  However, these 
margins were still diagnosed based on alternate criteria.  A margin was diagnosed as 
negative if a tumor was not circumferentially present.  However, if tumor cells were 
visible at the edge of the tissue sections, the margin was diagnosed as positive. 
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Table 10:  Enrollment table for the number of mice imaged in this study.  The 
respective number of negative and positive margins as diagnosed by a trained 
pathologist using post-operative H&E sections is also shown.   In some cases, the ink 
used to demarcate the relevant margin was lost during the fixing and staining process.  
Within each classification, it is further specified whether the pathologist was able to 
find the ink on corresponding H&E. 
 Diagnosed as NEGATIVE Diagnosed as POSITIVE 
Ink visible on H&E 4 12 
Ink lost on H&E 4 3 
 
4.2.2 MSER Optimization Results 
The first step in the image analysis was to optimize the MSER specifically for the 
images acquired with the SIM system to segment and quantify AO-stained features.  
However, as mentioned in the methods section, three specific parameters 
(MaxVariation, MinDiversity and Delta) were tuned to ensure the algorithm was 
accurately segmenting AO-stained features primarily arising from nuclei.  A dataset 
consisting of 10 tumor, 10 skeletal muscle, and 10 adipose images were used to optimize 
the parameters.  One representative image of each tissue type is shown in Figure 26.   
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Figure 26:  Representative SIM images of three different tissue types 
commonly found in margin images, tumor, muscle, and adipose tissues.  For the 
smaller ROIs, both the sectioned and uniform images are shown to demonstrate the 
enhanced contrast that SIM provides.  Examples of H&E micrographs are also shown, 
but it should be noted the H&E is not taken from the exact site of the corresponding 
SIM images. 
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The results from the optimization procedure are shown in Figure 27 where the 
corresponding area fraction (averaged over all 10 images of each respective tissue type) 
is plotted for the case where one parameter is varied while the other two are held 
constant. 
 
Figure 27:  Plots that demonstrate the effect of three different MSER 
parameters on segmented area fraction for tumor, muscle, and adipose images (Shown 
in previous figure).  The parameter Delta shows the most impact on area fraction, 
while MaxVariation and MinDiversity have a minimal effect. 
The MSER output appears to not be sensitive to MaxVariation and MinDiversity, 
in that varying these parameters has minimal effect on area fraction.  For the 
MaxVariation parameter, it appears that the area fraction begins to reach a plateau after 
values higher than 10.  It was calculated that the area fraction only increased by about 
10% after exceeding a MaxVariation of 10.  In MinDiversity, almost the entire range is a 
plateau and the area fraction shows very little variability regardless of the setting (15%).  
In contrast, varying Delta had the most significant impact on area fraction with the only 
visible plateau occurring when all area fractions fell to 0.  Ultimately, a MaxVariation of 
10 and MinDiversity of 0.5 were selected as these were within their respective plateau 
ranges.  However, selecting Delta was much more challenging as there was no 
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reasonable plateau range to choose within.  To determine the best Delta value, the 
segmented images for three representative images for Delta values between 2 to 14, 
shown in Figure 28, were visually inspected.  Images with Delta > 14 were not included 
in visual inspection because the area fraction value of the tumor began to converge with 
the adipose, which does not match the physiological expectation. 
 
Figure 28:  Series of images which demonstrate the impact of changing Delta 
on MSER AO-stained feature segmentation.  The calculated area fraction for each 
image is displayed on the bottom right.  As shown in the previous plot, the 
  94
segmented area fraction varies greatly as Delta changes. Ultimately, a Delta value of 
10 was chosen as the segmented nuclei appeared to be the most physiologically 
accurate. 
In the set of images shown in Figure 28, the original SIM images have been 
overlaid with false-coloring to represent the segmented areas identified using MSER.  
Specifically, green regions were smaller areas with a diameter of less than 10 µm and red 
regions were larger areas with diameters larger than 10 µm.  The diameters were 
calculated by measuring the longest axis of a segmented region.  Additionally, the 
distributions of measured segmented region diameters are also shown on the bottom 
row of Figure 28. 
Delta = 10 yielded the most appropriate and physiologically accurate in 
segmentation results across the representative images.  At Delta values of 2 and 6, it was 
clear that the images were over-segmented.  This was particularly obvious when 
inspecting the representative muscle images where extensive areas inside the fiber 
bundles were segmented.  While the whole muscle fiber is indeed stained with AO, the 
features closely related to nuclei should be located on the periphery of the fiber bundles, 
not in the center.  For Delta = 14, the images were under-segmented, meaning some AO-
stained features were not identified.  Specifically, the adipose image under this Delta 
value clearly displays nuclei that are not highlighted.  The three representative images of 
tumor, muscle, and adipose are shown in Figure 29 with the finalized MSER parameter 
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set.  Both the sectioned and uniform images are included to demonstrate the importance 
of contrast enhancement through SIM. 
 
Figure 29:  Application of the finalized set of MSER parameters to both the 
uniform and sectioned representative image set.  It is evident that the sectioned 
images provide a clear benefit with contrast enhancement which assists the MSER 
algorithm in accurately identifying nuclei.  The finalized set of MSER parameters 
used for these segmentation results were MinArea=3, MaxArea=15, MinDiversity=0.5, 
MaxVariation=2.5, and Delta=10. 
4.2.3 Tissue Type Classification Model Results 
As expected, the margin-level images clearly contained a mix of various tissue 
types including tumor, muscle, fat, blood vessels, nerves, and more.  The goal was not 
necessarily to separately identify every tissue type within a margin, but simply to 
identify any presence of tumor tissue.   This would lead to the conclusion that the 
presence of tumor is positive and conversely, the absence of tumor would be negative. 
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Following the procedure in the methods section, the training dataset of 30 tissue 
specific images was subdivided into n=1260 50x50 pixel bins.  The area fraction, average 
diameter, and average shape were calculated for all bins based on the MSER 
segmentation output.  These calculated values of all bins from the training dataset are 
displayed as boxplots and shown in Figure 30. 
 
Figure 30:  Distribution functions of the three variables, area fraction, 
diameter, and shape.  These include all 50x50 pixel bins from the training dataset, 
N=420 tumor bins and N=840 normal bins (420 muscle and 420 adipose).  A Wilcoxon 
rank-sum test was used to compare the distributions and calculate the corresponding 
p-value.  Based on the results, the tumor and normal distributions were statistically 
different in all three variables, so they were included as input to the logistic 
regression model. 
This data was input into the logistic regression to estimate coefficients for β0, β1, 
β2, β3.  First, the classification model was constructed using all three of input variables.  
Three additional classification models were constructed using two input variables, 
where one variable was left out of each iteration and the estimated coefficients of each 
model is shown in Table 11. 
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Table 11:  The estimated coefficients from the logistic regression model for 
classifying tissue types. 
 
Variables Used in Logistic Regression 
Area Fraction 
Average Diameter 
Average Shape 
Area Fraction 
Average Diameter 
 
Area Fraction 
 
Average Shape 
 
Average Diameter 
Average Shape 
β0 2.659 1.374 -4.460 1.3587 
β1 44.074 43.818 30.12 N/A 
β2 -0.962 -0.870 N/A -0.2114 
β3 -0.8652 N/A 12.09 -5.1622 
 
Using these estimated, the predictor value g(x) was calculated for each bin.  Then 
using this predictor value, g(x), as the binary classification parameter, a receiver 
operating characteristic (ROC) curve was generated by varying the classification 
threshold and is shown on the left side of Figure 31.  For comparison, three other ROC 
curves are also shown that were generated from a logistic regression models built using 
only two of three variables. 
 
Figure 31:  The receiver operating characteristic (ROC) curve on the left was 
generated when logistic regression model was applied to the original training dataset 
of 30 site specific ROIs (10 tumor sites and 20 normal sites).  The specific 
combinations of variables used as input to the logistic regression model are shown in 
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the legend.  The ROC curve on the right was the result of applying the same logistic 
regression model on separate validation dataset containing 25 new site specific ROIs 
(10 tumor sites and 15 normal sites). 
As shown by the ROC curve, the model performed exceptionally well (AUC=0.9), 
although this was expected since the model was simply applied to its training dataset.  
To test the true efficiency of the site level model, a separate validation dataset was 
selected.  This validation dataset contained 25 additional images (10 tumor, 10 muscle, 5 
adipose) that were separate from the training dataset.  Only 5 adipose images were 
selected for this validation dataset due to the smaller number of adipose sites found in 
the original dataset of 23 margins.  As with the training dataset, each image in the 
validation dataset was divided into the 50x50 pixel bins and the model predictor value 
 ( ) was calculated for each bin.  The ROC curve for the validation dataset is shown in 
right side of Figure 31. 
4.2.4 Application to Full Margin Images 
The final step of the analysis was to take site level predictive model and apply it 
to the full margin images.  The margin size from each mouse varied based on the tumor 
size, but most margins were covered using 4 to 6 separate images.  The typical image 
configuration of the margins was either 2x2 or 2x3.  In order to fully visualize each 
margin, multi-image mosaics were generated by placing each image site in its proper 
physical location, while also accounting for the overlap among adjacent images.  
Selected examples of one positive and one negative margin are shown in Figure 32. 
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Figure 32:  Example of a positive and negative margin imaged with the SIM 
system.  These images were viewed by a pathologist who labeled likely regions of 
tumor (T) and muscle (M). 
Following the procedure of the site level images, MSER was then applied to these 
two full margin images to segment AO-stained features.  The segmentation results of the 
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sectioned images are shown in Figure 33.  Again, segmented nuclei with diameters less 
than 10 µm were false colored in green, while those greater were colored in red. 
 
Figure 33:  These are the same positive and negative margin examples from the 
previous figure.  The images have been analyzed with MSER and the segmented AO-
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stained features are highlighted in green (diameter < 10 μm) and red (diameter > 10 
μm). 
Finally, the segmented images from the whole margins were divided into the 
smaller 50x50 pixel bins used as input for the site level predictive model.  This analysis 
was performed on the two margins shown in Figure 33 and four additional margins (a 
total of 3 positive and 3 negative).  The area fraction, average diameter, and average 
shape were calculated for each bin within the margin and the predictor value, g(x), was 
determined.  This data is shown in Figure 34 as a cumulative distribution function (CDF) 
of all bins from the respective positive and negative margins.  A boxplot of the same 
data is also shown on the right side of this figure. 
 
Figure 34:  Each margin was divided into smaller 50x50 pixel bins and each bin 
was analyzed using the site level predictive model.  Based on the output of the model, 
a tumor probability (%) was assigned to each bin.  As expected, the CDFs from the 
sectioned images (left) show a larger portion of the positive margin bins were 
assigned a higher tumor probability resulting in clear separation between the positive 
and negative margin CDF.  However, the CDFs from uniform illumination images 
(right) did not exhibit as much separation, indicating the importance of the contrast 
enhancement using SIM. 
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4.3 Discussion 
Without question, intraoperative diagnosis of surgical margins continues to be a 
challenging prospect.  The presence of a positive surgical margin requires a secondary 
procedure that impacts the patients, physicians, and healthcare providers.  Most 
importantly, the patient will undergo continued emotional stress and potential financial 
burdens from the additional operations. In the study presented here, it was 
demonstrated that SIM microscopy with AO staining is a feasible solution to 
intraoperative margin assessment.  This conclusion was drawn from using the SIM 
system to image surgical margins from a sample size of 23 spontaneous mouse 
sarcomas. 
The accurate and specific identification of cell nuclei is a vital step to determining 
the presence of tumor tissue.  Pathologists heavily base their classification decision on 
qualitative visual analysis of nuclear, size, shape, and density.  Similarly, in order for 
SIM microscopy to be clinically viable, it would not only need the ability to visualize, 
but also segment nuclei, preferably through an automated algorithm.  Visual inspection 
of SIM images acquired on AO-stained tissue clearly revealed that nuclei appeared as 
small local intensity maxima.  The decision to incorporate MSER as the method of 
automatically segmenting nuclei was based on the expected morphological appearance 
of nuclei in different tissue types.  The goal of applying a segmentation algorithm was to 
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identify the smaller AO-stained features that likely represented cell nuclei, rather than 
the larger AO-stained features, such as muscle fibers. 
Due to the relatively large field of view (>3 mm2) compared to confocal 
sectioning microscopy, a typical SIM image from the sarcoma margin would commonly 
contain more than a single type of tissue.  Pure tumor tissue consists mostly of tumor 
cells with very little or no other organizational structure.  However, the density of the 
tumor tissue can vary, so tumor nuclei can potentially appear with a dark or bright 
background.  Muscle nuclei are located on the periphery of muscle fiber bundles, which 
are also brightly stained with AO.  As a result, nuclei associated with muscle typically 
appear on a bright background.  In adipose tissue, the nuclei are also located on the 
periphery of an adipocyte, but lipid droplet that occupies the majority of adipocyte does 
not emit fluorescence from AO.  The adipose nuclei would appear on a mostly dark 
background, with fine streaks of background fluorescence from the connective tissue. 
Given the variety of tissue types and the respective differences in nuclear 
appearance, a simple global threshold was not an appropriate option.  MSER was a more 
robust algorithm with the potential to identify nuclei in complex tissue types.  The 
approach allows the intensity threshold to be selected locally, which is ideal due to the 
wide range of nuclei appearance.  The segmented images shown in Figure 29, clearly 
demonstrate the ability of the algorithm to highlight nuclei among tumor, muscle, and 
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adipose tissues.  As expected, the area fraction of segmented nuclei was higher in the 
tumor image by a factor of 3.51 over the muscle image and 1.70 over the adipose image. 
Once it was demonstrated that nuclei were automatically segmented using the 
MSER algorithm, the focus was to develop a predictive model to distinguish and classify 
different tissue types.  Area fraction, average diameter, and average shape were selected 
is parameters since they were quantifiable metrics of pleomorphic changes that 
pathologists use to identify tumor tissue in H&E.  Based on the ROC curves 
demonstrating its performance, the model was able to classify tumor and normal tissue 
with 77% sensitivity and 81% specificity (Youden’s index).  For an unbiased measure of 
the model performance, it was applied to a separate validation dataset that resulted in 
73% sensitivity and 80% specificity.   
It should be noted that the two example margins selected in Figure 32 are very 
clear examples of respective positive and negative margins.  In the negative margin, the 
only visible tissue type was muscle tissue while the positive margin example also 
contained muscle, but a clear identifiable tumor in the bottom right.  These margins 
were originally given their diagnosis by the pathologist who reviewed the post-
operative H&E slides.  She accurately re-diagnosed (blinded to her original diagnosis) 
each margin using only the SIM images and identified the specific muscle and tumor 
tissue regions. 
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A total of 6 margins (3 positive and 3 negative, including the two in Figure 32) 
were selected for the CDF plot on Figure 34.  It was clear from these plots that the site 
level logistic regression model was also producing expected results when applied to the 
full margin images.  Specifically, less than 8% of the bins from the selected negative 
margins were predicated to have a tumor probability of >50%, while over 25% of the 
bins from the positive margins were assigned a >50% tumor probability.  This 
observation was in agreement with our expectation since a larger portion of bins from 
the positive margins should be associated with higher tumor probability.  
Understandably, the next logical step would be to demonstrate the performance 
on all 23 mice imaged for this study.  However, once the algorithm was applied to all 
margin-level images, the clear separation between positive and negative margins was no 
longer present.  The increase in sample size revealed the lack of robustness in the site 
level classification model.   As previously explained, the site level tissue classification 
model was based solely on a subset of images consisting of tumor, muscle, and adipose 
tissue.  While it was true that tumor, muscle, and adipose tissue are the most common 
occurring tissue types, a closer inspection of all 23 margins indicated the presence of a 
number of other tissue types.  The pathologist confirmed these other tissue types on the 
H&E sections and also through inspection of the SIM images.  The presence of other 
highly cellular tissues was a source of error, which the site level classification model 
incorrectly assigned high tumor probabilities.  Some examples include, skin, lymph 
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nodes, nerve bundles, and bone marrow, which are all benign tissue types, but are also 
dense with cell nuclei.  Unfortunately in our 23 margin dataset, these additional tissue 
types appeared far less frequently than tumor, muscle, and adipose.  Due to this 
limitation, there was an inadequate amount of representative images to include in the 
training dataset for the site level tissue classification model. 
Despite the limitations, it has been demonstrated that SIM imaging combined 
with MSER nuclei segmentation is a powerful tool for distinguishing tumor from muscle 
and adipose tissue. Staining tissue with AO was a straightforward procedure that 
required only topical application and no specialized tissue or contrast agent preparation.  
This allowed the resected tumor to be rapidly imaged after excision (<15 min), a critical 
requirement for potential intraoperative use.  Finally, we have laid the groundwork for 
future studies and potential modifications to improve the system. 
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5. Conclusions 
The primary goal of this dissertation was to improve upon existing biophotonic 
solutions to address the unmet clinical need of surgical tumor margin assessment.  
Specifically, the ability to quickly and accurately identify residual disease can drastically 
improve patient care.  Although our focus was on breast cancer and pre-clinical 
sarcoma, the need for intraoperative margin assessment can be extended to virtually any 
organ site where surgical treatment is needed to de-bulk a tumor.  The extensive review 
of previous works reveals an academic and clinical interest in harnessing optical 
technologies for this specific healthcare application.  The clinical utility of DRS has been 
clearly demonstrated in not only our group, but many others as well.   Its unique ability 
to quantify biochemical molecules enables detection of physiological changes for 
differentiating tumor and normal tissue. 
As presented in chapter 2, the objective was to reduce the overall cost and 
physical footprint of a clinical DRS system.  Specifically, I proposed to construct a new 
compact DRS system where the detector in the clinical system, a cooled CCD, was 
replaced with low-cost silicon photodiodes.  This change to the system immediately 
reduced the overall cost of the system by over $15,000.  In addition to the changes on the 
detection path, the method of illumination was also modified to include an 8-channel 
filter wheel.  By sequentially launching discrete wavelengths into the tissue, the 
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expensive and physically cumbersome grating-based spectrometer was no longer 
required.  Again, with this change, the cost of the system was reduced another $10,000. 
Once redesigning the system and replacing these key components, it was 
important to determine the impact on system performance.  The sensitivity of a scientific 
grade cooled CCD was far superior to that of an off-the-shelf silicon photodiode.  
Additionally, in opting to use the filter wheel for illumination, the number of 
wavelengths to interrogate the tissue was reduced from a continuous spectrum (over the 
range of 400-600 nm) to 8 discrete wavelengths.  The latter goal of this chapter was 
demonstrating the new compact system performed equivalently to the original clinical 
system despite the loss in detection sensitivity and reduction in wavelengths in 
reconstructing the spectra. 
It was experimentally determined that the compact DRS system yielded an SNR 
(40 dB), system drift (±3%) and inter-pixel cross talk (1-9%) which were all on par the 
original clinical system.  Most importantly, the ability to accurately extract optical 
properties was shown on a set of tissue mimicking liquid phantoms.  The compact DRS 
system yielded an optical property extraction accuracy of 6.40 ± 7.78% for the absorption 
coefficient (µa) and 11.37 ± 19.62% for the wavelength-averaged reduced scattering 
coefficient (µs’) as compared to 9.03% for the absorption coefficient (µa) and 7.3% for the 
wavelength-averaged reduced scattering coefficient (µs’) in the original clinical system. 
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As shown in previous work, DRS relied on accurately quantifying the scattering 
coefficient, µs’, to distinguish tumor and normal tissue types.  Tumor tissue is expected 
to have a higher scattering coefficient, but unfortunately, certain benign tissue types, 
such as fibro-glandular tissues, are also highly scattering.  The inherent lack of spatial 
resolution in diffuse reflectance spectroscopy (on the scale of mm, rather than µm) led 
us to explore other optical technologies.  In order to distinguish fibro-glandular tissue 
from malignant tissue, a new optical technology with resolution on the micron scale was 
required to identify the cellular structures.  Fluorescence microscopy was selected due to 
its ability to generate high- resolution images for visualizing tissue microstructure.  In 
combination with the appropriate contrast agent, fluorescence microscopy was capable 
of visualizing cell nuclei and other micro-morphological structures without requiring 
extensive sample preparation. 
Though the approach was not without drawbacks, as the resected tumor mass 
removed from a patient is relatively thick in terms of optical path length.  In the realm of 
optical microscopy, sample thicknesses greater than a 1-2 mm pose a unique challenge.  
For fluorescence microscopy, a physically thick tissue sample would be difficult to 
image due to the large amount of unwanted background fluorescence.  To address this 
issue, we chose to design the system with SIM capabilities to reject the unwanted 
background fluorescence. 
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In Chapter 3, I presented a design and carried out a procedure to characterize a 
wide field fluorescence SIM system.  The measured basic imaging parameters were a 
single-shot FOV of 2.1×1.6 mm (3.4 mm2) and sub-cellular lateral resolution (4.4 µm).  
While SIM has been used for background rejection for nearly two decades, there has 
been limited application to thick intact biological samples.  The objectives of this chapter 
were to measure the relationship between illumination pattern frequency and optical 
sectioning strength and signal-to-noise ratio in turbid (i.e. thick) samples for selection of 
the optimum frequency, and to determine feasibility for detecting residual cancer on 
tumor resection margins, using a genetically engineered primary mouse model of 
sarcoma. The SIM system was tested in tissue mimicking solid phantoms with various 
scattering levels to determine impact of both turbidity and illumination frequency on 
two SIM metrics, optical section thickness and modulation depth. To demonstrate 
preclinical feasibility, ex vivo 50 µm frozen sections and fresh intact thick tissue samples 
excised from a primary mouse model of sarcoma were stained with AO, which stains 
cell nuclei, skeletal muscle, and collagenous stroma. The cell nuclei were segmented 
using a high-pass filter algorithm, which allowed quantification of nuclear density. The 
results showed that the optimal illumination frequency was 31.7 µm−1 used in 
conjunction with a 4×0.1 NA objective (ῦ = 0.165). This yielded an optical section 
thickness of 128 µm and an 8.9x contrast enhancement over uniform illumination. I 
successfully demonstrated the ability to resolve cell nuclei in situ achieved via SIM, 
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which allowed segmentation of nuclei from heterogeneous tissues in the presence of 
considerable background fluorescence. Specifically, it was demonstrated that optical 
sectioning of fresh intact thick tissues performed equivalently in regards to nuclear 
density quantification, to physical frozen sectioning and standard microscopy. 
Finally, the SIM system was applied to a larger dataset of 23 animals to 
demonstrate clinical viability and the study design with corresponding results were 
shown in Chapter 4.  The biological samples used in this study were a genetically 
engineered mouse model of sarcoma, where a spontaneous solid tumor was grown in 
the hind leg.  After the tumor was surgically removed from the animal and the relevant 
margin was stained with AO and then imaged with the SIM system with the primary 
goal of visualizing specific morphological changes in cell nuclei.  To automatically 
segment nuclei, rather than using a simple high-pass filter, an algorithm known as 
maximally stable extremal regions (MSER) was optimized and applied to the images.   
As an intermediate step prior to diagnosing whole margins, a tissue-type 
classification model was developed to differentiate localized regions (75x75 µm) of 
tumor from skeletal muscle and adipose tissue based on the MSER nuclei segmentation 
output.  A logistic regression model was used which reported a final output in terms of 
probability (0-100%) the tumor within the localized region.  Using this output as a 
binary classifier, the model performance was tested using an ROC curve analysis that 
revealed 77% sensitivity and 81% specificity.  For margin classification, the whole 
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margin image was divided into localized regions and the tissue-type classification model 
was applied.  In a subset of 6 margins (3 negative, 3 positive), it was shown that at a 
tumor probability threshold of 50% only 8% of all regions from a negative margins 
exceeded this threshold, while over 25% of all regions exceeded the threshold in the 
positive margins. 
In summary, Table 12 shows a comparison of the two optical technologies that 
were presented in this dissertation.  It should be noted that the purpose of this table is 
not for direct comparison of the two systems, as the technologies are inherently 
different.  However, the table does point out the specific strengths of each technology 
and the specific gaps that each can fill.  DRS is superior in terms of ability to image 
whole margins (<20 min) due to significantly larger FOV.  Additionally, DRS is capable 
of detecting close margins with a clinically relevant sensing depth (2-3 mm).  On the 
other hand, SIM has the capability of visualizing individual cells and differentiating 
tissue types at the microscopic level. 
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Table 12:  Comparison of the two optical systems which were develop for 
surgical tumor margin assessment 
Optical 
Technology 
Lateral 
Resolution 
Single-Shot 
FOV 
Sensing 
Depth 
Single Site 
Acquisition 
Time 
Source of 
Contrast 
Compact DRS 5.8 mm ~20x20 mm 2-3 mm 10 sec [Hb] 
[HbH] 
[beta-carotene] 
µs’ 
SIM system 4.4 µm 2.1 x 1.5 mm ~100 µm 1-3 sec From AO stain: 
Cell Nuclei 
Fibrous Tissues 
 
5.1 Future Work 
5.1.1 Combination of DRS and SIM Imaging 
While the focus of my work was a modular approach focusing on improvements 
to DRS and SIM separately, based on Table 12 the strength of each technique would fill 
the gaps of the other.  On their own, each technology has been systematically validated 
on both pre-clinical and clinical settings.  A combination of the two technologies can 
potentially yield a system that is sensitive to both changes in biochemical properties and 
nuclear morphology.  However, simply combining the two technologies that I 
specifically developed is not a feasible solution.  In particular, the compact DRS system 
presented in Chapter 2 requires direct contact with the sample, while the SIM system 
(Chapters 3 and 4) is noncontact.  Fortunately, our group has continued to improve 
upon the compact photodiode DRS system.  The latest iteration of the system involves 
the photodiode array, but the illumination light is delivered thorough a back-lit 
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geometry.  In addition, a lenslet array aligned to the photodiode apertures is used to 
focus the light into the tissue.  The result of these modifications is a noncontact form of 
the compact DRS system.  Other groups have also presented concepts for non-contact 
DRS [108]. 
 
Figure 35:  A system schematic for a combination DRS and SIM imaging 
system.  The primary advantage would be to utilize the fast scanning and coverage 
ability of DRS, while also maintain the ability to visualize high-risk regions with the 
high spatial resolution of SIM 
To combine these two technologies, a potential system design is shown in Figure 
35.  The advantage of implementing this system is that the light source would be used 
for both system and majority of the optical path would be the same.  In this 
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implementation, the Fianium laser is used due to its broadband output (400-1300 nm) 
and a filter wheel would be used to select the appropriate wavelengths required for DRS 
and fluorophore excitation in SIM.  A simple flip mirror is added in the optical path to 
select between the two systems. 
Ideally, the first step would be to image sample using DRS to take utilize of the 
inherent acquisition speed and coverage advantage.  If a certain region is identified as 
high risk, then the SIM system can be used to rescan the region at microscopic resolution 
to confirm the assessment from DRS.  Clearly, there will be some spatial offset between 
the FOV of the DRS system and the FOV of the SIM system, so the exact same region 
cannot be imaged simultaneously with both systems.  However, these spatial locations 
can be easily calibrated and accounted for using a programmable automated translation 
stage. 
5.1.2 SIM System Technical Improvements 
Though I have demonstrated the ability of the SIM system to image biological 
samples in mouse sarcomas, a number of technical improvements can be made to 
increase the system viability.  In its current form, the image acquisition time for sarcoma 
tissue is 1-3 seconds.  This is compounded by the fact that SIM requires three images to 
be captured at each location.  For this technique to be truly scalable to larger human 
surgical margins, the acquisition time must be reduced.  There are some potential 
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technical improvements that can be implemented in the system to reduce the acquisition 
time.  
The current SIM system delivers 1.3 mW of 480 nm light to the sample.  
Increasing the excitation power is a potential solution to decreasing the acquisition time.  
The main concerns in raising the optical power are patient safety and photobleaching.  
Regarding patient safety, because all proposed imaging takes place ex vivo, the optical 
power limit is not necessarily the same as if the light was applied directly on the patient.  
The true danger would be in unintentional scattered or reflected light that could pose a 
threat to the patient, physician, and/or operator.  An increase in excitation may cause the 
contrast agent to photobleach and cease to emit fluorescence.  A straightforward study 
can be carried out to determine to photobleaching limit of AO both in aqueous solution 
and in biological samples.  In order to increase the excitation power, a new source must 
be explored.  Laser diodes or LEDs can provide a feasible option cost significantly less 
than the Fianium laser source. 
Finally, if an increase in excitation power is not a viable option, then the current 
objective may be replaced with another objective with a higher NA.  The NA is generally 
related to the single image FOV, so it would be important to determine this trade-off.  
However, a significant reduction in acquisition time can negate the decrease in FOV.  If 
multiple images with a smaller FOV can be acquired faster than a single large FOV, then 
there is still a decrease in overall imaging time.  As an example, if the current 4x 
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objective is replaced with a 10x objective, the FOV will be decreased by a factor of 2.5.  
Fortunately, the typical NA of a 10x objective (Nikon PlanFluor) is 0.3, so the collection 
efficiency will actually increase by a greater factor, 3. 
5.1.3 Identification of Additional Tissue Types 
During the course of the 23 sarcoma margin study presented in Chapter 4, I 
presented the results of applying the SIM system to a study of 23 sarcoma margins.  A 
portion of this work focused on developing an algorithm to differentiate tumor, muscle, 
and adipose tissue.  While it was true that tumor, muscle, and adipose tissue are the 
most common occurring tissue types, a closer inspection of all 23 margins indicated the 
presence of a number of other tissue types.  The pathologist confirmed these other tissue 
types on the H&E sections and also through inspection of the SIM images.  The presence 
of other highly cellular tissues was a source of error, which the site level classification 
model incorrectly assigned high tumor probabilities.  Some examples include, skin, 
lymph nodes, nerve bundles, and bone marrow, which are all benign tissue types, but 
are also dense with cell nuclei.  Examples SIM images of a nerve bundle and bone 
marrow are shown in Figure 36.  Unfortunately in our 23 animal dataset, these 
additional tissue types appeared far less frequently than tumor, muscle, and adipose.  
Due to this limitation, there was an inadequate amount of representative images to 
include in the training dataset for the site level tissue classification model. 
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Figure 36:  Images of a nerve bundle, bone, and bone marrow acquired with 
the SIM system.  These tissue types were not as common as tumor, muscle, or adipose, 
however due to their high cellular contact these were a source of false negatives in the 
margin images.  Scale bars are 200 µm. 
Additional studies should be conducted to specifically harvest and image a 
larger set of normal tissue types.  The site level model can then be trained and re-
optimized on a larger of tissue types to increase its robustness.  Another important 
consideration is that the introduction of additional tissue types can also impact the 
MSER nuclei segmentation.  The segmentation performance would be important to 
verify prior re-developing the site level model. Using representative images of these 
new tissue types, the same MSER optimization procedure outlined in this study should 
be followed to validate performance on a broader range of tissues. 
5.1.4 Multi-spectral Contrast in SIM 
Through this work, it has been clearly demonstrated that AO is an appropriate 
contrast agent for visualizing cell nuclei.  Its high fluorescence yield generates more than 
enough signal for the SIM system to detect.  An additional feature of AO that has not 
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been explored is its spectral-dependent features.  AO is known to be a metachromatic 
dye—in monomeric form its fluorescence emission peak is 525 nm, the peak is shifted to 
590-630 nm [109].  It has been reported that AO tends to aggregate between myofibrils in 
skeletal muscle [109].  Thus, imaging the two emission peaks of AO could in identifying 
where muscle is located within an image. 
In order to obtain spectral information from the SIM system, the emission filter 
must be replaced with a tunable filter, so that a corresponding image can be acquired for 
each wavelength.  A 50 µm tissue section containing both tumor and muscle was imaged 
at all emission wavelengths (Figure 37A) as well as discrete spectral bins through using 
a liquid crystal tunable filter (LCTF).  A combined image of the monomeric emission 
peak (530 nm) and the aggregated emission peak (630 nm) is shown in Figure 37B with 
the corresponding H&E stained section shown in Figure 37C.  The skeletal muscle in the 
upper right hand corner primarily emits fluorescence at the longer red wavelength, 
while the tumor region in the left half of the image primarily emits fluorescence at the 
shorter green wavelength.  
  120 
 
Figure 37:  Multi-spectral properties of AO. (a) An tissue section image of 
tumor + muscle imaged with all emission wavelengths. (b) An overlay of 530 (green) 
and 630 nm (red) emission. (c) Corresponding H&E stained section. 
For multi-spectral imaging, either additional emission spectra from AO can be 
collected or additional fluorophores could be used to stain different tissue components. 
Either AO or other fluorophores can be incorporated into the imaging protocol in order 
to acquire multi-spectral image sets.  Additional possibilities for fluorophores that have 
been identified include AlexaFluor568 Phalloidin or LipidTox Deep Red. AlexaFluor568 
Phalloidin selectively stains F-actin, which is present in skeletal muscle, and has an 
excitation and emission peak of 578 and 600 nm respectively [110]. LipidTox Deep Red 
Neutral lipid stain has a high affinity for neutral lipid droplets, and has an excitation 
and emission peak of 577 and 609 nm respectively [111].  
5.1.5 Validation of Image Processing Algorithms 
A vital portion of margin analysis using the SIM system was the proper 
segmentation of nuclei within the images.  In Chapter 3, the concept was first introduced 
using a simple high pass filter.  A more advanced algorithm called MSER was 
implemented in Chapter 4 with an extensive procedure to optimize on specific tissue 
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types.  The optimization of the MSER algorithm was based primarily on a priori 
knowledge of tissue physiology and expected location of nuclei.  Though cell nuclei are 
clearly seen, no direct study was carried out to determine if segmented areas definitively 
corresponded to actual cell nuclei.  An additional study has been proposed to use mice 
expressing the red-fluorescence protein (RFP) gene.  By adding the RFP gene to 
adenovirus transfection sequence, the nuclei corresponding to sarcoma tumor cells will 
emit peak fluorescence at 584 nm with peak excitation at 555 nm.  Alternatively, a 
secondary contrast agent that stains only nuclei can be used as a counter-stain to verify 
nuclei location. 
Additional studies are also being performed on a larger dataset of frozen tissue 
sections.  Imaging frozen sections provide a good correlation to H&E (as shown in 
Figure 18) since the slide can be immediately fixed and stained after imaging.  However, 
it would be important to keep in mind that the tissue morphology can be slightly altered 
between fresh and fixed tissue.  Primarily, tissue sections are known to undergo some 
shrinkage from the dehydrating and cross-linking process when submerged in formalin.  
If a quantitative comparison is desired, an automated image processing algorithm must 
be implemented on the images.  MSER could potentially be applied to the H&E images, 
however a similar optimization procedure would need to be followed to ensure accurate 
segmentation.   Co-registering the exact FOV between the SIM and H&E image can be 
challenging unless prominent features are present in the images. 
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An additional goal of acquiring the larger sample size of frozen section images 
was to further optimize the SIM illumination frequency to determine if there is a 
relationship between contrast enhancement and automated nuclei segmentation.  
Images were acquired using multiple objectives, 2x, 4x, and 10x, multiple physical tissue 
thicknesses, and multiple illumination frequencies.  MSER will be applied to all images 
acquired to first understand at what physical section thickness structured illumination + 
MSER shows improvement over uniform illumination + MSER.  Secondly, this 
information will be used to determine which frequency yields the optimal performance 
of MSER for each objective. 
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